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ABSTRACT 
Fish oil, rich in omega-3 polyunsaturated fatty acids, is known to decrease plasma 
triacylglycerol concentrations mainly by decreasing plasma very-low density lipoprotein (VLDL) 
levels. However, the influence of fish oil supplementation on plasma low-density lipoprotein 
(LDL) cholesterol concentrations is controversial. Human populations with type-2 diabetes 
mellitus show a significant increase in LDL-cholesterol concentration when fed high fat fish oil 
diets. However, the mechanism for this increase is not known. We used F1B hamsters, a model 
susceptible for high fat diet-induced type-2 diabetes mell itus. Hyperlipidemia was induced by 
feeding dietary cholesterol. The hamsters were fed diets rich in either fish oil or a MIX oil to 
investigate whether fish oil has beneficial effects in lowering plasma lipid and lipoprotein levels. 
We found that fish oil at high fat levels caused a significant increase in chylomicron like 
particles, even after 14 hrs of fasting. The plasma LDL- and VLDL-cholesterol concentrations 
were significantly higher where as HDL-cholesterol concentration was significantly lower in fish 
oil fed hamsters especially at high fat levels. The hepatic microsomal triglyceride transfer protein 
(M1TP) activity was not significantly altered by fish oil, suggesting that increased levels of 
plasma VLDL is not due to increased production in the liver. The plasma cholesteryl ester 
transfer protein (CETP) activity in fish oil fed hamsters was lower compared to the MIX diet fed 
hamsters, thus this increase in LDL-cholesterol concentration and decrease in HDL-cholesterol 
concentration in fish oil fed hamsters are not a result of increased CETP activity. It appears that 
the clearance of lipoproteins is inhibited in fish oil fed hamsters. In conclusion, fish oil feeding 
especially at high fat levels might not be beneficial in treating hyperlipidemia under certain 
pathophysiological conditions. 
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Chapter 1: Introduction 
1.1 Health effects of fish oil 
Fish oil is well known to protect against coronary heart disease. The first report 
supporting the view that dietary fish oil prevents coronary heart disease was made in the 
1950s by a Seattle cardiologist, Nelson who observed a 4-fold reduction of coronary heart 
disease following increased fish intake (Dyerberg, 1986). Epidemiological studies on 
the health effects of fish oil began with observational studies conducted in a coastal 
settlement of Greenland Eskimos in the 1970s by Bang and Dyerberg. It was observed 
that the polyunsaturated fatty acid content of the diet was very high among the Eskimo 
population compared to Danes (Bang eta/. 1976; Dyerberg, 1986). 
Eskimos had an incidence of heart disease that was estimated to be about 8% of 
that seen in a comparable population in Denmark (Kromann and Green, 1980). In Japan, 
where fish consumption is traditionally high, a concomitant shift in tissue lipid 
composition favoring n-3 PUFA has been interpreted as causative of a relatively low 
incidence of cardiovascular thrombotic disorders (Hirai, 1980). Recently, Krornhout et 
a/. (1995) reported the protective effect of fish oil intake in relation to coronary heart 
disease in a sample of 272 elderly people who were followed for 17 years. 
The beneficial effects of fish oil are reported to be due to the n-3 polyunsaturated 
fatty acid (n-3 PUFA) content offish oil. The 1st double bond ofn-3 PUFA is at the 3rd 
carbon atom of the carbon chain from the methyl end. The major n-3 PUF A found in fish 
oil are eicosapentaenoic acid (EPA, 20: 5) and docosahexaenoic acid (DHA, 22: 6). 
Pfeiffer et al. (1962) showed that defatted fish flesh had no effect on plasma cholesterol 
levels in rats, whereas oil that was extracted from the flesh lowered cholesterol levels, 
suggesting that the active component in fish is fish oil. When human subjects were given 
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the saturated plus monounsaturated and polyunsaturated fractions of sardine oil, plasma 
lipid lowering effect resided only in the latter (Imachi et al., 1963). Furthermore, the 
effects of fish oil on lipid metabolism have been largely reproduced by purified n-3 
PUF A (Nossen et al., 1986). Considering the weight of this evidence it is fair to state 
that n-3 PUF A in fish oil are primarily responsible for fish oil induced changes in lipid 
metabolism. 
Plasma lipid and lipoprotein levels were measured in representative group of 
Eskimos and compared to an age and sex matched group of Danes (Bang et al., 1972). 
Total lipids, cholesterol and triacylglycerols, very-low density lipoproteins (VLDL) and 
LDL (low-density lipoproteins) levels of plasma were lower and HDL (high-density 
lipoproteins) levels were higher in Eskimos compared to the Danes. Although similar 
changes in lipids and lipoproteins have been observed by feeding fish oil in many other 
clinically controlled studies, there are many differences between Eskimos and people in 
industrialized countries in their behavior such as, exercise, cigarette smoking, genetic 
variability, alcohol use. Some of these factors may also contribute to the differences in 
incidence of coronary heart disease. 
1.2 Possible mechanisms of amelioration of coronary heart disease by fish oil 
1.2.1 Plasma triacylglycerol concentrations and coronary heart disease 
Increased plasma triacylglycerol concentrations are known to be associated with 
increased risk of coronary heart disease, but the role oftriacylglycerol levels as an 
independent risk factor remains unclear. For the first time Zilversmit (1979) proposed 
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that cholesterol ester-enriched chilomicron remnants, found in the postprandial phase are 
as atherogenic as LDL. Since then it has been shown that increased postprandial 
triacylglycerol concentrations are associated with the formation of small cholesterol 
ester-rich chylomicron remnants, which share the ability to mediate cholesterol influx 
into the arterial intima along with LDL (Shaikh eta!., 1991 ). In addition, there is a recent 
body of evidence to support the hypothesis that postprandial triacylglycerol metabolism 
plays a causal role in the pathogenesis and progression of coronary heart disease (Karpe 
and Hamsten, 1995; Bergeron and Havel, 1997). 
1.2.2 Fish oil and fasting plasma triacylglycerol concentrations 
It has been established that fish oil suppresses plasma triacylglycerol 
concentrations in both fasting (Wong et al., 1984; Surette eta!., 1992b) and postprandial 
states (Ikeda eta!., 2001). The reduction in plasma triacylglycerol concentrations by fish 
oil in the fasting state is ascribed to the suppression ofhepatic secretion ofVLDL 
triacylglycerols (Nossen et al., 1986; Wong and Paul, 1987). Several human studies have 
examined the mechanism oftriacylglycerol-lowering effect offish oil. Harris et al. 
(1984) found that n-3 polyunsaturated fatty acids prevented and rapidly reversed 
carbohydrate-induced hypertriglyceridemia in normolipidemic subjects. Since 
carbohydrate feeding is known to stimulate triacylglycerol synthesis and VLDL secretion 
(Mancini et al., 1973), this finding suggested that fish oil inhibits hepatic triacylglycerol 
synthesis. Kinetics ofVLDL apolipoprotein B (apoB) and triacylglycerols in normal 
human subjects and hypertriglyceridemic patients were examined by Nestel et al. (1984). 
They found that the triacylglycerollowering effect was mainly attributed to hepatic 
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triacylglycerol production rather than increased removal. According to this study, the 
synthesis rates ofVLDL apoB and triacylglycerol are reduced by more than 50%. 
Experiments on both human (Wong et al., 1987) and animal (Wong et al. 1985; Nossen 
et al., 1986,) hepatic cells have further shown that n-3 PUP A from fish oil inhibit hepatic 
triacylglycerol synthesis and secretion. 
Low doses offish oil (Sanders et al., 1985) as well as high doses offish oil 
(Connor et al., 1986) inhibit VLDL triacylglycerol synthesis. Several human studies 
have shown that n-3 PUF A from fish oil reduce fasting plasma triacylglycerol 
concentrations dose dependently (Sanders and Roshanai, 1983; Blonk et al., 1990; 
Schmidt eta/., 1990). When the data from these studies were pooled, it emerged that the 
change in fasting plasma triacylglycerollevels is correlated with the dose of n-3 PUP A 
intake (R2=0.874) (Roche and Gibney, 2000). However, it would be interesting and 
beneficial to observe whether this dose dependent hypotriglyceridemic effect of fish oil 
would exist at very high dietary fat levels (using an animal model) in order to assure the 
safety ofhigh therapeutic doses offish oil. 
1.2.2.1 Possible mechanisms for decreased triacylglycerol secretion by fish oil 
Several studies have documented inhibition of hepatic triacylglycerol secretion by 
n-3 PUP A found in fish oil. Suppressed triacylglycerol synthesis as well as decreased 
apolipoprotein B (apoB) production can affect hepatic triacylglycerol secretion since 
apoB is an essential component of the VLDL particle. Nossen et al. (1986) observed that 
incubation of cultured rat hepatocytes with n-3 PUP A decreased hepatic triacylglycerol 
synthesis while there was no influence on apoB production, in comparison to cells 
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incubated with oleic acid. On the other hand, reduction of both triacylglycerol and apoB 
synthesis has been reported following incubation of cultured human hepatoma cells with 
n-3 PUP A (Wong et al., 1986) and rat hepatocytes (Christopher et al., 1990). A 
randomized controlled trial using obese men showed that fish oil effectively lowers the 
plasma concentrations oftriacylglycerols chiefly by decreasing VLDL apoB production 
(Chan et al., 2003). 
Wong et al. (1984) demonstrated that the reduction in triacylglycerol synthesis 
was accompanied by increased hepatic fatty acid oxidation in perfused livers from rats 
fed a fish oil diet. In addition, feeding a fish oil diet for 2 weeks caused a significant 
increase in peroxisomal ~ oxidation activity of fatty acids in rats compared to the 
safflower oil diet fed counterparts (Yamazaki et al., 1987). These data suggest that the 
fish oil induced increased fatty acid oxidation can result in lower hepatic fatty acid levels, 
hence decreased triacylglycerol synthesis. Interestingly, the peroxisomal proliferation 
seen with fish oil is also seen with clofibrate, a drug, which also lowers triacylglycerol 
levels. However, unlike clofibrate, fish oil does not reduce the activity of detoxifying 
enzymes and thus fish oil may be safer than the drug (Yamazaki et al., 1987). 
It has been observed that n-3 polyunsaturated fatty acids are less efficiently 
activated to acyl-CoA, or EP AIDHA-CoA and they are poor substrates for triacylglycerol 
synthesis as compared to saturated fatty acids and monounsaturated fatty acids (MUF A) 
(Nessen et al., 1986). This observation is consistent with other studies indicating that 
saturated fatty acids are preferentially incorporated into triacylglycerol (Davis and 
Boogaerts, 1982). Diversion ofn-3 polyunsaturated fatty acids from pathways of 
esterification as a major factor in triacylglycerollowering effect of fish oil has also been 
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suggested (Wong et al., 1985). In addition to the effects ofn-3 PUPA on triacylglycerol 
formation, an inhibitory effect on de novo fatty acid synthesis and reduction in acetyl-
CoA carboxylase activity in rat livers has been reported (Iritani et al., 1980). 
Wilkinson et al., 1998 provided evidence to suggest that n-3 PUF A perturb 
intracellular events in VLDL assembly and hence decreased VLDL secretion. Feeding 
fish oil to rabbits caused an interruption of intracellular apoB transfer and hence 
decreased assembly ofVLDL particles. 
Although there is no clear biochemical mechanism, the studies cited above have 
suggested a potential role of decreased fatty acid and apoB synthesis, increased fatty acid 
oxidation, decreased acylCoA formation and perturbed intracellular events in VLDL 
assembly, in fish oil-induced decreased triacylglycerol secretion from the liver. 
1.2.2.2 Microsomal Triglyceride Transfer Protein {MTTP) regulation by fish oil 
Triacylglycerol is concentrated within the hydrophobic core of apoB during the 
assembly ofVLDL. MTTP is implicated in the acquisition oftriacylglycerol by nascent 
apoB for assembly and secretion ofVLDL (Kulinski et al., 2002). Studies done on 
hamsters have shown that the amount and type of dietary fat can affect hepatic MTTP 
mRNA expression. Incremental increase of dietary fat level increased hepatic MTTP 
mRNA expression significantly in a dose dependent manner in hamsters fed a diet rich in 
saturated fatty acids and MUFA (Bennett et al., 1995). The nature ofthe dietary fatty 
acids also influenced MTTP mRNA expression; diets rich in saturated fatty acids 
elevated MTTP mRNA levels significantly compared to the diets rich in MUF A or n-6 
PUF A in hamsters (Bennett et al. , 1995). However, mRNA levels for MTTP were not 
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affected by either fish oil or com oil, when rat hepatocytes were incubated with fish oil or 
com oil chylomicron remnants (Botham et al., 2003). However, when cells were shifted 
to a pro-oxidizing state by pretreatment with CuSo4 for 24 hr, levels ofmRNA for MTTP 
were increased by 2 fold by fish oil chylomicron remnants, whereas com oil remnants 
had no significant effect. These changes would be expected to lead to an increase in 
VLDL secretion rather than decrease by n-3 PUF A. Thus, the role of MTTP in fish oil-
induced suppression ofVLDL secretion is questionable. On the other hand, the 
possibility of variation of fish oil-induced changes in MTTP activity due to species or 
strain specific metabolism should also be considered. 
1.2.3 Postprandial bypotriglyceridemic effect of fish oil 
The postprandial triacylglycerolemic response refers to a series of metabolic 
events that occur after ingestion of a fat containing meal. Several clinical studies have 
shown that postprandial lipemia is an important factor in the pathogenesis and 
progression of coronary heart disease (Groot et al., 1991 ). It has been further observed 
that the concentration of postprandial chylomicron remnant apoB 48 is directly related to 
the rate of progression of coronary heart disease (Karpe et al., 1994). 
In the postprandial state three lipoprotein species can be affected; chylomicrons, 
chylomicron remnants and VLDL. However it is not known whether chylomicrons, 
chylomicron remnants, and VLDL are all affected equally with fish oil intake. Harris and 
Connor (1980) reported that consuming a diet rich in salmon oil blunts the postprandial 
rise in plasma triacylglycerollevels, but this effect was only observed when the subjects 
were on a fish oil background diet. Inhibition of the postprandial response by n-3 PUF A 
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could be due to slower formation or faster removal of chylomicrons and VLDL or a 
combination of these factors. 
1.2.3.1 Effect of fish oil on Intracellular chylomicron formation 
The rate of chylomicron formation is affected by the digestion and absorption of 
fat and intracellular metabolic events. Only a few studies have investigated the digestion 
ofn-3 PUFA -rich triacylglycerols. It was observed that, EPA and DHA of marine oil are 
relatively resistant to pancreatic lipase mediated hydrolysis (Bottino et al., 1967). 
Decreased absorption of n-3 PUF A has been reported especially when these fatty acids 
are in esterified form. Chen eta/. (1985) observed that enteral infusion of EPA is 
absorbed equally as oleic acid in animals. However when fish oil (which contain 
esterified EPA) was infused, it was absorbed more slowly than com oil (Chen et al., 
1987). This observation suggests that digestion rather than absorption of these fatty acids 
has an impact on postprandial response. Furthermore, Herzberg et al. (1992) reported 
that, EPA and DHA from fish oil were effectively absorbed from the intestine compared 
to linoleic acid in rats previously adapted to diets containing fish oil. Thus, it is possible 
that duration of fish oil feeding may have an impact on digestion and absorption of fish 
oil. 
Although the influence of dietary n-3 PUF A from fish oil on intracellular 
chylomicron formation has been less studied, the effect of n-3 PUF A on intracellular 
metabolic events in hepatocytes has been extensively studied. As mentioned in section 
1.2.2.1 , n-3 PUF A are known to inhibit triacylglycerol synthesis in hepatocytes. Since 
triacylglycerol synthesis takes place in enterocytes during fat absorption, it is possible 
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that this process is likewise inhibited by fish oil, but there is no consistent evidence for 
this hypothesis. Cartwright and Higgins (1999) observed that enterocytes were less 
stimulated to synthesize and secrete chylomicron lipids, when rabbits were fed a fish oil 
diet for 2 weeks compared to sunflower oil diet. They further observed that decreased 
chylomicron synthesis was due to slow differentiation of enterocytes in to mature cells, 
giving new insight to potential fish oil-induced suppression of chylomicron production. 
1.2.3.2 Influence of fish oil intake on removal of chylomicron and VLDL lipids 
Decreased postprandial triacylglycerollevels observed with fish oil feeding may 
result from an increase in lipolytic rate of chylomicrons and VLDL or increase hepatic 
removal ofchylomicron remnants. Westphal et al. (2000) observed a significant 
reduction of chylomicrons and VLDL in the early hours of postprandial phase in n-3 
PUF A treated hypertryglyceridemic patients. They further observed increased removal 
of chylomicron remnants, but only in the late postprandial phase. Furthermore, Lambert 
et al. (200 1) reported an increase in hepatic uptake of chylomicron remnants that are rich 
in n-3 PUF A compared to chylomicron remnants rich in saturated fatty acids in 
chylomicron remnant perfused rats (Lambert eta/. 2001). The increase in n-3 PUPA-
enriched chylomicron remnant uptake was not influenced by hepatic lipase activity. 
These studies tell that the postprandial hypotriglyceridemic effect of fish oil might partly 
be due to increased removal of chylomicron and VLDL lipids and increased hepatic 
removal of chylomicron remnants. Furthermore, increased chylomicron remnant uptake 
is mediated through a mechanism that is independent of hepatic lipase activity and 
dependent on properties or composition of chylomicron remnants. 
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1.2.3.2.1 Effect of fish oil on intravascular chylomicron and VLDL lypolysis 
Lypolysis of chylomicron and VLDL triacylglycerols at peripheral tissues is 
facilitated by lipoprotein lipase, which is attached to the luminal surface of blood vessels. 
Mature lipoprotein lipase is secreted to the vascular endothelium mainly from the 
parenchymal cells of adipose and muscle tissues. The influence of n-3 PUF A on the 
activity oflipoprotein lipase and the rate of fatty acid release from n-3 PUPA-enriched 
chylomicron emulsions has been extensively studied, however, the results are 
controversial as described below. 
Increased lipoprotein lipase activity in adipose tissue (Anil et al., 1992; Benhizia 
et al., 1994; Yoshiba et al., 1999) and muscle (Herzberg and Rogerson, 1989) has been 
reported in n-3 PUF A rich diet fed rats compared to rats fed a :o.-6 PUF A-enriched diet. 
However, Ikeda et a!. (2001) observed a fish oil induced increase in adipose tissue 
lipoprotein lipase activity with no difference in post heparin lipoprotein lipase activity in 
rats. Since tissue lipoprotein lipase activity reflects the activity of both intravascular and 
intracellular (parenchymal) lipase pools, enzyme activity in adipose tissue is not an 
accurate indicator ofVLDL and chylomicron lipolysis. Thus, post heparin lipoprotein 
lipase activity (which measures intravascular lipoprotein lipase activity) and adipose 
tissue lipoprotein lipase mRNA expression is more representative of intravascular 
lipoprotein lipolysis than adipose tissue or muscle lipoprotein lipase activity. 
There is growing body of evidence for a decrease in post heparin lipoprotein 
lipase activity in fish oil fed swine (Groot et al., 1989; Huff eta!., 1993) and rats (Haug 
and Hostmark, 1987). Furthermore, Raclot et al. (1997) observed a reduction of 
lipoprotein lipase mRNA expression in retroperitonial tissues in DHA fed rats. A 
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decrease in lipoprotein lipase activity might be an adaptive response for the 
triacylglycerollowering effect offish oil. A positive correlation of fasting plasma 
triacylglycerol concentrations and lipoprotein lipase mRNA expression was observed by 
Murphy et al. (1999) in human subjects, which further suggests the possibility of 
adaptive change in enzyme activity with changes in plasma triacylglycerol 
concentrations. However, post heparin lipoprotein lipase activity remained the same in 
human subjects who were treated with fish oil (Nozaki et al., 1991; Desager et al., 1989; 
Harris et al., 1988). In contrast, Harris et al. (1997) and Zampe1as et al (1994) observed 
an increase in post heparin lipoprotein lipase activity in n-3 PUF A treated healthy human 
subjects. Above controversial results might be due to absence of in vivo conditions for 
the enzyme activity because in vivo lipoprotein lipase activity is known to be modified by 
other factors like apoCI, apoCII and apoE. 
Although lipoprotein lipase mediates the catabolism oftriacylglycerol-rich 
lipoproteins, the activity of this enzyme is not a direct indicator of in vivo hydrolysis of 
chylomicrons and VLDL. Several investigations have been done to study the effect of 
chylomicron and VLDL composition on the rate of lipoprotein lipase mediated fatty acid 
release, which is rather more representative of intravascular lipolysis than lipoprotein 
lipase activity. 
It has been observed that lipoprotein lipase selectively hydrolyses chylomicron 
triacylglycerols, which results in chylomicron remnants that are relatively enriched with 
EPA and DHA. Chylomicrons derived from animals and human subjects fed a fish oil 
diet have shown decreased lipolysis by lipoprotein lipase (Botham et al. , 1997; Levy and 
Herzberg, 1999). Furthermore EPA and arachidonic acid-rich chylomicrons exhibit a 
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relative resistance to lipoprotein lipase compared to fatty acid esters with the chain length 
ofC14-Cl8 (Melin eta!., 1991; Ekstrom et al., 1989). In vitro hydrolysis ofn-3 PUFA 
enriched emulsions by lipoprotein lipase and hepatic lipase showed relatively high 
resistance compared to n-6 PUFA enriched emulsions (Oliveira eta!., 1997). Kasim-
Karakas eta!., 1995 observed a reduction of the absolute rate oftriacylglycerollipolysis 
in hypertriglyceridemic patients following n-3 PUF A supplementation. All these 
observations suggest that chylomicrons enriched with n-3 PUF A are resistant to 
lipoprotein lipase mediated lipolysis. 
1.2.4 Coronary heart disease, LDL and fish oil 
The association between high levels ofLDL cholesterol and increased incidence 
of coronary heart disease is firmly established (Kinsella eta!., 1990). However, 
decreased LDL cholesterol concentrations by fish oil, as a causative factor for lower 
incidence of coronary heart disease remains questionable. While there are no direct data 
from which to answer the question, the reported reduction in atherosclerosis in swine fed 
fish oil (which occurred without lowering ofLDL) (Weiner eta!., 1986) would suggest 
that modification of LDL levels by fish oil may not play an important role in reduction of 
atherogenesis and hence, coronary heart disease. The growing body of evidence for an 
increase in LDL concentrations by fish oil diet also argues against the anti-atherogenic 
effect offish oil in terms ofLDL concentrations and its relation to increased incidence of 
coronary heart disease. It is likely that, in addition to the LDL concentrations, changes in 
chemical and physical properties ofLDL particles may also affect atherogenesis. 
Monkeys fed a fish oil diet incorporated large amounts ofEPA into LDL cholesterol 
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esters, which led to lowering of phase transition temperature of whole LDL particle 
(Parks and Gebre, 1987). A decrease in transition temperature of the LDL particles is 
known to be associated with reduced atherogenesity, thus, this observation suggests that 
n-3 PUF A induced changes in the LDL particle itself may inhibit atherogenesity. 
Although the effect of fish oil on plasma triacylglycerol and VLDL 
concentrations is well known, the effect on the regulation ofLDL and HDL cholesterol 
concentrations is inconsistent. This may be attributed to several factors, i.e. individual 
variations, lack of control of confounding factors, pre-existing dislipidemias etc. 
Normolipidemic subjects show reduction in plasma LDL-cholesterol concentrations 
following intake offish oil diet (Nestel eta!., 1986, lllingworth et al., 1984). However, 
fish oil supplementation to hyperlipidemic subjects causes an increase in LDL cholesterol 
concentrations (Sullivan et al., 1986, Hsu et al., 2000). 
Animal experiments also show varied effects of increased consumption of fish oil 
on plasma LDL-cholesterol concentrations. Fish oil feeding reduced LDL-cholesterol 
concentrations in African green monkeys (Parks and Crouse, 1992) but had no effect on 
LDL-cholesterol concentrations in Cynomolgus monkeys (Parks and Gebre, 1991). On 
the contrary, fish oil feeding to rabbits increased the LDL-cholesterol levels (Wilkinson 
et al. 1998). This inconsistency might be attributed to changes in lipoprotein metabolism 
in different animal species. Thus, we should be careful when interpreting and comparing 
the results of an animal model with human and other animal models. 
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1.2.4.1 Potential mechanisms 
. Several mechanisms have been proposed for both a reduction and an increase in 
plasma LDL concentrations by n-3 PUF A. Kinetic studies of 1251-LDL metabolism in 
normal human subjects disclosed a significantly lower rate of synthesis of LDL apoB by 
n-3 PUF A-enriched diet comparedto a control diet containing predominantly saturated 
fatty acids and MUF A (Illingworth eta/., 1984). Therefore, a concomitant increase or no 
change in LDL removal can result in low levels ofLDL. Rats fed an n-3 PUPA-enriched 
diet showed an enhanced LDL-receptor (LDLr) activity with lower plasma LDL levels 
compared to n-6 PUPA-enriched diet fed rats (Ventura eta/., 1989; Spady eta/., 1993; 
Spady eta/., 1995). On the other hand, an increased binding ofLDL to liver membranes, 
hence possibility of increased LDL clearance, has been reported in mice (Tripodi et al. 
(1991). Furthermore, Vasandani et al. (2002) reported that increased LDL uptake in n-3 
PUPA-enriched diet fed mice is not dependent on LDLr activity. These studies suggest 
that n-3 PUF A decrease LDL synthesis as well as increase LDL clearance resulting in 
decreased plasma LDL levels, although the mechanism is not clear. 
An increase in LDL concentrations can be explained by either increased LDL 
synthesis or decreased removal rate. LDL is synthesized from VLDL following 
hydrolysis and removal ofVLDL triacylglycerols. Although it might seem unlikely that 
lower VLDL levels can be associated with raised LDL levels, there is a possibility of 
independent secretion ofLDL particles (i.e. LDL that do not arise from VLDL) (Nestel et 
al., 1984). In addition, Harris (1989) hypothesized, considering the investigations done 
on metabolic differences between VLDL particles of different sizes, that there is a fish 
oil-induced increased production of smaller VLDL particles (although the total VLDL 
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level is low), which are known to be readily converted to LDL by lipoprotein lipase 
compared to larger particles. The possibility of decreased LDL removal can be explained 
by either decreased ability ofLDL to bind to LDLr or decreased synthesis ofLDLr. 
Monkeys which were injected with LDL obtained from fish oil fed animals showed 
decreased LDL clearance compared to their counterparts injected with LDL obtained 
from olive oil fed animals {Schectman et al. 1996). This effect may be due to alteration 
ofLDL particle size or composition, which reduces the affinity ofLDL for its receptor. 
On the other hand, fish oil induced decreased expression of hepatic LDLr mRNA that 
may lead to decreased LDLr mediated LDL uptake, has been reported in animal 
(Wilkinson et al., 1998) and human cell culture studies (Lindsey et al., 1992). 
LDL particle size and composition may be important determinants ofLDL 
clearance because changes in particle size are known to be associated withalterations in 
affinity to LDLr (Nigon et.al., 1991). Increased LDL particle size has been observed in 
hypertensive human subjects who were treated with fish oil compared to controls that 
were treated with com oil (Suzukawa et al., 1995) and in normal human subjects who 
were treated with EPA and DHA compared to base line particle size (Lindsey et al., 
1992). Sanchez-Muniz et al. (1999) reported an increase in the LDL cholesterol /LDL 
apoB ratio, which reflects a probable increase in LDL particle size in normal subjects 
following fish oil supplementation compared to saturated fatty acids and MUF A treated 
counterparts. In contrast, Cynomolgus monkeys who were fed a fish oil diet had smaller 
LDL particles, compared to lard fed monkeys (Parks et al., 1991, Linga et al. , 1993). 
The inconsistency in fish oil-induced changes in LDL particle size might be attributed to 
a lack of control for confounding factors, like MUF A, .PUF A, saturated fatty acid and 
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cholesterol content in the diet fed to the control group or lack of control of the pre-
interventional diet. 
· ill addition, the correlation ofLDL particle size with LDL binding affinity has 
also been studied. A proportional increase of fibroblast LDL uptake with increase in 
LDL particle size was observed in Cynomolgus monkeys by Linga eta/. (1993). 
Furthermore, the binding affinity ofLDLfrom monkeys was correlated with LDL 
particle size (Hannah eta/., 1997). However, Nigon eta/. (1991) demonstrated that 
larger or smaller LDL particles from humans had a lowerLDLr binding affinity than 
medium-sized LDL particles, hence slower turn over rate. These findings imply that 
alteration of particle size might have an impact on LDLr mediated LDL uptake, hence 
fish oil-induced changes in plasma LDL levels might partly be due to alteration in LDL 
particle size. 
1.2.5 Effect of fish oil on HDL 
The influence of fish oil on plasma HDL cholesterol concentration is also 
inconsistent. The HDL cholesterol concentrations increased upon intake offish oil in 
human trials done on normal subjects, but no effect of fish oil was observed in 
hyperlipidemic patients (Harris, 1996). In contrast, HDL cholesterol concentrations 
decreased in response to n-3 PUF A-enriched diet in studies done on hamsters (Surette et 
al. 1992a) and nonhuman primates (Ward and Clarkson, 1985). 
The HDL fraction compris~s mainly two sub fractions, namely HDLz and HDL3. 
Whether the protective effect ofHDL on coronary heart disease can be attributed to one 
or both HDL sub fractions remains unclear. The effect of fish oil supplementation on 
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HDL2 and HDL3 was reported in a few studies and t.he results of these studies are 
inconsistent. The HDL2 sub fraction is found to be lower in pat.ients onhemodialysis 
who were treated with MaxEPA, a concentrate ofn-3 PUFA (Rylance et al., 1986). 
However there were no controls for fat intake in this study. In contrast, a significant 
increase in HDL2/HDL3 ratio has been observed in hypercholesterolemic patients 
following fish oil diet (Abbey et al., 1990). Harris et al. (1988) observed no changes in 
HDL sub fractions in hyperlipidemic patients following fish oil supplementation 
compared to vegetable oil. The inconsistency of the results of fish oil induced changes in 
total HDL cholesterol and HDL subfraction concentrations might be due to lack of 
control of confounding factors like pre-existing dislipidemic state. 
1.2.6 Effect of fish oil on reverse cholesterol transport pathway 
The reverse cholesterol transport pathway, which removes cholesterol from 
perepheral tissues andretums itto the liver, is known to be one of the main determinants 
of the LDL and HDL lipid composition. Cholesteryl ester transfer protein (CETP) plays 
the major role in this pathway transferring cholesterol ester from HDL to VLDL and LDL 
in exchange for triacylglycerols (Quinet et al., 1991). While the effect ofn-3 PUFA on 
plasma lipoprotein levels has been extensively studied, less is known about the impact on 
reverse cholesterol ester transport. 
Bagdade et al. (1996) observed a dramatic fall in cholesterol ester transfer from 
HDL to LDL and VLDL in normolipidemic insulin dependent diabetic (IDDM) subjects 
who were treated with n-3 PUFA compared to pre-treatment levels, although, there was a 
paradoxical increase in mass ·ofCETP. Furthermore treating hypercholesterolemic men 
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with n-3 PUF A showed normalization of plasma cholesterol ester transfer compared to 
accelerated pre-treatment levels (Bagdade et al., 1992). Furthermore, HepG2 cells, 
incubated with EPA and DHA show a significant reduction in hepatic CETP mRNA 
expression (Hirano et al., 2001). Since the findings of above studies conducted on 
human subjects and a human cell line are consistent with decreased cholesterol ester 
transfer following dietary supplementation ofn-3 PUFA, these fatty acids may have a 
beneficial role in the nutritional therapy ofhyperlipidemia and IDDM as, accelerated 
cholesterol ester transfer is known to be atherogenic in those patients. In addition, the 
above studies suggest that, plasma CETP mass and/or CETP activity might not reflect 
actual cholesterol ester transfer from HDL to LDL and VLDL. 
1.2.6.1 Effect of fish oil on lecithin cholesterol acyl transferase (LCAT) activity 
LCAT plays an important role in the cholesterol ester transport pathway by 
catalyzing the esterification of free cholesterol in HDL particles. Using reconstituted 
HDL particles made of egg yolk lecithin-[14C] cholesterol-apoAl as exogenous substrate, 
it was found that there was no difference in plasma LCA T activity in fish oil diet fed 
monkeys compared to lard fed monkeys (Parks et al., 1989). However, n-3 PUFA are 
found to be less utilized by LCAT for formation of cholesterol esters; rather, LCAT 
preferentially utilizes linoleic acid (n-6 PUF A) for cholesterol ester formation (Parks et 
al., 1989; Parks et al., 1997). These data suggest that resistance ofn-3 PUFA for 
esterification may lead to decreased reverse cholesterol transport. 
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1.2.7 Pro-atherogenic effect of fish oil 
Decreased HDL concentration and increased LDL concentration is known to be 
proatherogenic. A Fish oil induced increase in LDL concentrations was consistently 
shown in studies done on patients with hyperlipidemia and type-2 diabetes mellitus. 
Therefore, fish oil might be proatherogenic at least in this part of human population. In 
addition, Hayes (1990) reported an elevation of the apoB to apoA1 ratio in Syrian Golden 
hamsters fed a fish oil diet. The increase in apoB/apoA1 ratio on fish oil feeding also 
point towards a pro-atherogenic effect of fish oil. 
Besides the possibility of a pro-atherogenic effect of fish oil, several studies have 
reported a hyperlipidemic effect of fish oil, which was more obvious in animals fed fish 
oil diet supplemented with cholesterol (Kubow eta!., 1996, Lu eta!., 1996, Lin eta!. 
1995, Surette eta!., 1992a). Although a similar effect was observed With a n-6 PUPA-
enriched diet supplemented with cholesterol, the effect of fish oil diet given along with 
cholesterol was significantly higher compared to n-6 PUF A-enriched diet (Lu et al., 
1996). This hyperlipidemic effect is mainly due to an increase in plasma VLDL and LDL 
cholesterol concentrations rather than an increase in triacylglycerol concentrations. Lin 
et al. (1995) observed an increase in total plasma VLDL and LDL cholesterol 
concentrations in Syrian hamsters who were fed a fish oil diet supplemented with 0.5% 
w/w cholesterol compared to hamsters fed a coconut oil diet or soybean oil diet 
supplemented with cholesterol. They further observed an attenuation of the 
hypotriglyceridemic effect of fish oil when the fish oil diet was supplemented with 0.5% 
w/w cholesterol. The hyperlipidemic effect of fish oil was dependent on the level of 
dietary cholesterol and dietary n-3 PUF A content (Surette et al., 1992). Syrian golden 
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hamsters consumed diets containing incremental increase in dietary n-3 PUF A from fish 
oil with 0.1% w/w cholesterol showed an increase in VLDL and LDL cholesterol 
concentrations with increase dietary fat level. However, with low dietary cholesterol 
(0.015% w/w), this dietary fat level dependent hypercholesterolemic effect offish oil was 
not seen (Surette at al., 1992a). These observations suggest that, in spite of the consistent 
demonstration ofhypotriglyceridemic effect of fish oil in human subjects, the hamster 
model behaves differently giving a fish oil-induced, dose dependent hyperlipidemic 
effect when there are moderate to high levels of dietary cholesterol. Furthermore, unlike 
human subjects, who show a fish oil-induced attenuation of the hypercholesterolemic 
effect of dietary cholesterol (Neste! et al., 1986), there is a dose dependent 
hypercholesterolemic effect of dietary cholesterol in hamsters fed a fish oil diet. 
The mechanism behind the hyperlipidemic effect of fish oil, supplemented with 
cholesterol is not clear. Lu et al. (1996) and Lin et al. (1995) have measured the activity 
ofacyl-CoA:cholesterol acyltransferase (ACAT), the enzyme which controls the rate of 
intracellular cholesterol esterification and 3 hydroxy-3-methyl glutaryl-CoA (HMG-
CoA), the enzyme that control the cholesterol synthesis, in Syrian golden hamsters fed a 
fish oil diet supplemented with cholesterol. The hepatic ACAT activity was significantly 
increased in hamsters fed a cholesterol supplemented fish oil diet compared to coconut 
oil and soybean oil counterparts. However, HMG-CoA activity was reduced in all the 
diet groups supplemented with cholesterol. Increased formation of cholesterol esters by 
increased ACAT activity might be a potential explanation for increased VLDL 
cholesterol concentrations by the cholesterol supplemented fish oil diet, although there is 
reduction in endogenous cholesterol synthesis due to decreased HMG-CoA activity. On 
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the other hand, the effect of the cholesterol supplemented fish oil diet on hepatic 
secretion ofVLDL in hamsters has not been studied. Thus, further investigations need to 
be carried out to understand whether increased cholesterol esterification is associated 
with increased hepatic secretion ofVLDL. 
Another possible mechanism for this hyperlipidemic effect is decreased 
catabolism ofVLDL and/or chylomicrons. McAteer et al. (2003) demonstrated dietary 
cholesterol-induced increase in VLDL and chylomicron levels in F 1B hamsters due to 
suppression of plasma lipoprotein lipase activity. Thus, the possibility of decreased 
lipolysis as a cause of this hyperlipidemic effect of cholesterol supplemented fish oil has 
to be explored. 
A possible role of oxidative stress in the hyperlipidemic effect of fish oil has also 
been studied. Dietary supplementation of vitamin E could prevent the fish oil-induced 
hyperlipidemic effect in hamsters (Kubow et al., 1996), indicating the reduced 
antioxidant capacity as a contributing factor. However, the mechanism behind oxidative 
stress related hyperlipidemia in fish oil fed hamsters is yet to be studied. 
1.3 Hamster as an animal model to study the diet induced regulation of lipid 
metabolism 
The hamster is widely used as an animal model to study the effects of diet on 
lipoprotein metabolism and atherosclerosis since the lipoprotein profile of hamster 
resembles closely that of humans. Moreover, the hamster is highly susceptible to 
atherosclerosis (Nistor et al., 1987). Increases in plasma lipid concentrations could be 
easily induced in hamsters by adding only small, physiological amounts of cholesterol to 
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the diet (Kowala et al., 1991). In addition, the hamster has similar plasma CETP activity 
to that seen in humans whereas, other animal models, like the pig, rat and mouse have 
virtually no plasma CETP activity (Ha and Barter, 1982). 
The F 1B hamster is a hybrid offspring of Bio 87.2 and Bio 1.5 parent strains and it 
is an excellent animal model for hyperlipidemia and atherosclerosis. Feeding an 
atherogenic diet to F 1B hamsters results in elevated plasma cholesterol levels, but this 
increase is, in contrast to other strains of hamsters, more pronounced in the VLDL and 
LDL fraction than in the HDL fraction (Kowala et al., 1991). In addition, compared to 
the DSNI (dominant spot normal inbred) strain, F 1B hamster showed more susceptibility 
to hyperlipidemia and atherosclerosis due to increase in triacylglycerol rich lipoproteins 
i.e., chylomicrons and VLDL, following dietary supplementation of cholesterol (McAteer 
et al., 2003). As a consequence, the HDL to total plasma cholesterol ratio is lower in the 
hyperlipidemic F1B hamster than in other hyperlipidemic hamster strains. This makes the 
hyperlipidemic F 1B model more comparable to the human situation, as hyperlipidemic 
human subjects also show lower HDL to total plasma cholesterol ratio. In addition, the 
F1B hamster is suggested to develop type-2 diabetes mellitus when fed high fat diets, 
which makes this model comparable to the human population with this dyslipidemic 
disorder. 
1.4 Justification of this study 
Data from previous studies suggest that the amount of fish oil might have varied 
effects on LDL- and HDL-cholesterol concentrations under normal or hyperlipidemic 
conditions. This study was designed to investigate the regulation of lipid and lipoprotein 
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metabolism by fish oil, at various fat levels, under normal and hyperlipidemic conditions. 
We used the F 1B hamster, a model suggested to develop type-2 diabetes mellitus when 
fed high fat diets. Hyperlipidemia was induced by feeding high cholesterol diets. The 
animals were fed either a diet rich in fish oil or a mixed oil (MIX) diet to investigate 
whether fish oil has beneficial effects in lowering plasma lipid levels. 
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Chapter 2: Methodology 
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2.1 Animals and diets 
The FlB hamsters (7 weeks old) were obtained from Bio Breeders Inc. (Water 
Town, MA) and fed a chow diet for one week prior to feeding specific diets. After this 
equilibration period, hamsters were divided into 8 groups (n=12) and each group was fed 
with one of the specified diets. The specified diets consisted of fat free semipurified diet 
(ICN Biomedical Inc., OH) that was supplemented with either fish oil (menhaden oil, 
Sigma Chemical Co., St. Louis, MO) or a mixture of lard and safflower oil in 1.5:1 ratio 
(MIX diet) from local supermarket. The composition of the semipurified diets with fat 
and cholesterol is given in Table 1. The fat content of the diets was either 5% w/w (low 
fat) or 20% w/w (high fat). Due to the presence of cholesterol in fish oil, the low f~t fish 
oil diet contained 0.025% w/w of cholesterol, and the high fat fish oil diet contained 0.1% 
w/w of cholesterol. Thus, the same amount of cholesterol was added to the low fat and 
the high fat MIX diets to keep cholesterol content similar. To get high cholesterol 
contents the fish oil and MIX diets were supplemented with additional cholesterol to 
bring the final concentration of cholesterol to 0.25% w/w. Highest purity grade finely 
powdered cholesterol (98% pure, Sigma-Aldrich, St. Louis, MO) was dissolved in fat and 
added to the diets. Lipids were extracted from the diets and the fatty acid composition 
was analyzed using gas liquid chromatography (Keough and Davis, 1979). The fatty acid 
composition of the diets is given in Table 2. All diets were stored at - 20° C. 
All animals were housed in individual cages in a single room with enriched 
environment. The room was lit from 07:00 to 19:00 hours, with temperature maintained 
at 21° C and humidity at 35±5 %. The animals were given fresh diets every day for two 
weeks. The diet consumption was checked every day. The animals were weighed at the 
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Table 2.1 Composition (g/kg) of the semipurified diets designed for a 5% (w/w) or a 
20% (w/w) fat level. 
Diets 
Ingredient* 
Low fat 3 Low fat 3 High fat4 High fat4 
FO MIX FO MIX 
(g/kg) 
Casein 201 201 200 200 
DL-Methionine 3 3 3 3 
Sucrose 500 500 306 306 
Com starch 150 150 200 200 
Vitamin Mix 1 11 11 11 11 
Mineral Mix 1 35 35 40 40 
Fibe~ 50 50 50 50 
Fat 50 50 200 200 
Cholesterol 0.25 0.25 1 1 
*Ingredients were from ICN Biomedicals, Cleveland, OH, USA. 
1Supplied in quantities adequate to meet NRC requirements (National Research Council, 
1995) 
2Cellulose was supplied as Alphacel non-nutritive bulk (ICN Biomedicals Inc., Aurora, 
OH). 
3Semipurified diet designed for a 5% (w/w) fat level. 
4Semipurified diet designed for a 20% (w/w) fat level. 
Abbreviations used; FO, fish oil diet 
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Table 2.2 Fatty acid composition of the diets. Lipids were extracted from the diets and 
fatty acid composition was determined by gas chromatography. Abbreviations used: 
L:SF A, sum of saturated fatty acids, L:MUF A, sum of monounsaturated fatty acids, 
L:PUFA, sum of polyunsaturated fatty acids, ND, not detected. 
Fatty acids Fish oil MIX 
%w/w 
14:0 9.6 1.0 
16:0 19.3 19.3 
16:1 n7 13.1 2.0 
18:0 3.8 10.0 
18:1 13.8 31.0 
18:2 n6 2.7 34.0 
18:3 n3 4.5 3.0 
18:4 n3 3.4 ND 
20:1 n9 1.6 ND 
20:4 n6 1.0 ND 
20:5 n3 12.9 ND 
22:5 n3 2.4 ND 
22:6 n3 12.0 ND 
L:SFA 32.0 30.0 
L:MUFA 28.0 32.0 
L:PUFA 38.0 37.0 
L:n-3 PUFA 35.0 3.0 
L:n-6 PUFA 3.0 34.0 
n-6/n-3 ratio 0.09 11.3 
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beginning of the study period, one week later and at the conclusion of the study. After 
two weeks on specified diets the animals were sacrificed after 14 hrs of fasting. Blood 
was collected by cardiac puncture into tubes containing EDTA (1.2 mg/ml, 
pH 7.4) and centrifuged immediately at 3000 x g, 4° C for 15 minutes (Pless, 1991) to 
separate plasma. 10% NaN3 was added (lJ.Ll/ml) to each plasma sample to prevent 
bacterial and fungal growth. Plasma samples were stored on ice at 4° C. Liver and 
adipose tissue were removed and quick-frozen in liquid nitrogen. The tissues were stored 
at - 70° C until further use. 
2.2 Plasma lipoprotein isolation 
2.2.1 Separation of chylomicrons 
Plasma from high fat fish oil diet (20% w/w) fed hamsters was milky and 
contained chylomicron-like particles. Plasma was centrifuged at 15,500 g for 20 min at 
12° C (McAteer et al., 2003) to separate chylomicrons that were stored at 4° C for further 
analysis. The infranatant (remaining plasma which contain other lipoproteins) was 
separated and used for isolation of other lipoproteins. 
2.2.2 Micropreparative lipoprotein isolation 
For serial isolation of individual lipoprotein fractions, solutions containing 
increasing amounts ofNaCl or NaBr were used to sequentially adjust the density of 
plasma (Bauer, 1991, Salter et al., 1998). For this procedure, 0.5 ml of plasma was 
mixed with d=1.0063 NaCl (0.5 ml) containing 0.01% w/w EDTA in 1 ml tubes to adjust 
the final density of the mixture to d=l.006. Tubes ware centrifuged at 100,000 RPM for 
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2.5 hrs at 16° C; acceleration, 5; deceleration, 7 using TL 100 fixed angle rotor (Beckman 
instruments, Inc., CA). After centrifugation, the top 0.5 ml (d< 1.006) was aspirated and 
labeled as VLDL. The bottom layer (0.5 ml) was mixed with d= 1.12 NaCl (0.5ml) 
containing 0.01% w/w EDTA to adjust the final density to d= l.060 and centrifuged under 
conditions described above. The top layer (0.5 ml, d=l.006-1.060) was aspirated and 
labeled as LDL (LDL fraction contained both IDL and LDL). Remaining bottom layer 
(0.5 ml) was mixed with d= 1.36 NaBr containing 0.01% w/w EDTA to adjust the final 
density to d=l .20 and centrifugation repeated under above conditions for 3.5 hrs. After 
centrifugation, the top layer (0.5 ml, d=1.060-1.20) was removed and labeled as HDL. 
Isolated individual lipoprotein fractions i.e. VLDL, LDL and HDL were stored at 4° C for 
further analysis. 
2.3 Plasma, lipoprotein and liver lipid analysis 
Lipids were extracted from liver samples by homogenizing 50 mg of liver in 2 ml 
chloroform/methanol (2:1) (Folch et al., 1957). The lower organic phase was dried under 
nitrogen, and resuspended in 100 ~-tl of isopropanol. 
Total cholesterol concentration was assayed in plasma, chylomicron like 
particles,VLDL, LDL, HDL and liver lipid extracts using cholesterol assay kit# 402 
(Sigma Diagnostics Inc, St. Louis, MO). Total triacylglycerol concentration was assayed 
in plasma, VLDL, LDL, HDL and liver lipid extracts using triglyceride assay kit# 344 
(Sigma Diagnostics Inc, St. Louis, MO). Free cholesterol was assayed in plasma, 
individual lipoprotein fractions and liver lipid extracts using free cholesterol assay kit 
(Wako Chemicals, VA). Cholesterol ester concentration was determined by subtracting 
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the free cholesterol concentration from total cholesterol concentration. Phospholipid 
concentrations of plasma lipoprotein fractions were analyzed using the method ofBartlett 
eta/. (1959). Surface lipid content and core lipid content ofLDL particles represent the 
sum of free cholesterol and phospholipid concentrations (surface lipid) and the sum of 
cholesterol ester and triacylglycerol concentrations (core lipid) ofLDL respectively. 
2.4 Lipoprotein lipase activity 
2.4.1 Extraction of lipoprotein lipase from adipose tissue 
Lipoprotein lipase extraction, preparation of apoCII source and lipoprotein lipase 
enzyme assay was performed using a previously published method (Nilsson and Schotz , 
1976). White adipose tissue ofhamsters (500 mg) was chopped and homogenized in 2.5 
ml of ice-cold water containing 20 J..lg/ml heparin. The homogenate was placed on ice for 
30 min to separate aqueous phase and lipid phase. The lower aqueous phase (1 ml) was 
taken and mixed with ice-cold acetone (5 ml) and 100 J..lg/ml BSA (40 ~-tl). The mixture 
was placed on ice for 1 hr and then centrifuged at 2300 RPM for 10 min at 0° C. The 
pellet was washed with ice-cold acetone (5 ml) and recentrifuged under above conditions. 
The pellet was resuspended in ice-cold diethylether (5 ml) and centrifuged under similar 
conditions. The diethylether was poured off and pellet was dried under nitrogen. The 
dried pellet was stored at -70° C for analysis of lipoprotein lipase activity. 
31 
2.4.2 Preparation of apoCII source 
Hamster blood was collected by cardiac puncture into a glass tube and incubated 
at 37° C for lhr. Blood was centrifuged at 1,100 rpm for 20 min to separate serum. 
Serum was collected into a fresh glass tube using a pasteur pipette and heated at 56° C in 
an oven for 1 hr to inactivate lipoprotein lipase enzyme. Serum was stored at -20° C as 
the source of apoCII. 
2.4.3 Purification of Tri [9,1 0-3H] oleoyl glycerol and preparation of stock glycerol 
emulsion 
150 j.!l (750 j.!Ci) oftri [9,10-3H] oleoyl glycerol was obtained from Amersham 
Pharmacia Biosciences (QB)and purified by running on a TLC plate developed in a 
solvent system containing hexane: diethylether: acetic acid (80:20:1). Triolein was used 
as the standard. Tri [9,10-3H] oleoyl glycerol band was cut and extracted with 
chloroform: methanol (2:1) to prepare the stock glycerol emulsion. Triolein (414 mg) 
and phosphatidylcholine (20 mg) were added to a vial containing purified tri [9,10-3H] 
oleoyl glycerol (750 j.!Ci) and mixed. The mixture was dried under N2, glycerol (30 ml) 
was added to the tube and resulting mixture was sonicated (at 45 amplitude) for 4 times at 
1min intervals. The stock glycerol emulsion was stored at room temperature. 
2.4.4 Lipoprotein lipase (LPL) enzyme assay 
The LPL pellet (section 2.4.1) was resuspended in 600 j.!l of 20 mM Tris/HCl 
containing 20 j.!g/j.!l heparin and left on ice for 30 min. The assay was standardized for 
the optimum volume ofLPL extract. To stay within the linear range, 50 J.Ll of LPL 
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extract was used for all the assays. LPL extract (50 J..ll) and 0.15 M NaCl (25 J..ll) were 
added to a glass tube and preincubated at 30° C for 15 min. Boiled LPL extract (50 J..ll) 
was used as the blank. The reaction was started by adding diluted glycerol emulsion (50 
J..ll). Diluted glycerol emulsion consisted of 0.62 M Tris!HCl containing 5% BSA at pH 
8.6 made up in 0.15 M NaCl: serum (apoCII source): stock glycerol emulsion at the ratio 
of 1: 0.5: 1. Incubation was continued at 30°C for 60 min in a shaking water bath. 
Reaction was stopped by adding 1.625 ml ofmethanol: chloroform: heptane (1.45: 1.25: 
1) and 0.525 ml of 0.1 M potassium bicarbonate-potassium tetrabotrate buffer (pH 1 0.5). 
Each tube was vortexed for 30 seconds and then centrifuged at 1,100 rpm for 10 min at 
25° C. Upper phase (0.5 ml) counted in a scintillation counter and enzyme activity was 
expressed as pmolfhr/mg adipose tissue. 
2.5 Microsomal triglyceride transfer protein (MTTP) assay 
Liver (100 mg) was homogenized in 1m] ofbuffer containing 10 mM Tris, 150 
mM NaCl and 1 mM EDTA at pH 7.4. The homogenate was sonicated at 45 amplitude 
(x 3) at 1 min intervals and stored at -70°C. MTTP activity in the liver homogenate was 
assayed using the MTTP Activity kit (Roar Biomedical Inc., Columbia University, NY). 
The assay was standardized to determine the optimum amount of protein in the linear 
range. To stay within the linear range, 1.5 mg of protein was used for all the assays. The 
homogenate (1.5 mg protein) was combined with 5 Jll of"acceptor" (VLDL), 5 1-11 of 
"donor" (synthetic triacylglycero]s linked to a fluorescent labeled nitrobenzooxadiazole-
fluorophor) (NBD-TG) in 250 1-11 total volume of buffer (1 0 mM Tris, 150 mM NaC1, 1 
mM EDTA at pH 7.4). Boiled homogenate (1.5 mg protein) was used as the blank. The 
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reaction mixture was incubated at 37° C for 3 hrs and transferred to a 96-well black 
microplate. The fluorescence was measured using Spectra Max Gemini fluorescence 
spectrophotometer, at an excitation wavelength of 465 nm and an emission wavelength of 
535 nm. The fluorescent neutral lipid is present in a self-quenched state when contained 
within the core of the "donor". The MTTP-mediated transfer is determined by the 
increase in fluorescence intensity as the fluorescent lipid is removed from the self-
quenched "donor" to the "acceptor". The fluorescence readings were standardized to 
pmol triacylglycerol transferred/hr by plotting a standard curve according to the 
manufacturer's instructions to derive the relation between fluorescence intensity and 
mass transfer generated by dispersing the "donor" in isopropanol. The unquenched 
fluorescence intensity ofthe fluorescent neutral lipid contained within the core of the 
"donor" was detennined by dispersing 5 J..ll of "donor" in 2 ml of 100% isopropanol. 
Serial dilutions of the dispersion were made to generate a standard curve of fluorescence 
intensity (excitation 465 nml emission 535 nm) versus mass of fluorescent cholesterol 
ester. MTTP activity was expressed as pmol/hr/mg. 
2.6 Cholesteryl ester transport protein (CETP) activity assay 
CETP activity in the plasma samples was assayed by a previously published 
radioactive method (Tall et al., 1987). Lipoproteins (LDL; density 1.024-1.063 and 
HDL; density> 1.125) were isolated from human plasma (Murdoch and Breckenridge, 
1994) and the HDL fraction was radiolabled, using 14C-cholesterol oleate purchased from 
Amersham Pharmacia Biosciences (QB) (Tall et al., 1987). The assay was standardized 
to determine the optimun1 volume of plasma to be in the linear range. For further 
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experiments 5.111 of plasma was used to stay in the linear range. The assay was also 
standardized to determine the optimum incubation time. To stay within the linear range, 
1 hr ofincubation time was used for all assays. Plasma (5 111) was combined with 
radiolabeled HDL (5 11g), LDL (50 11g) and 115 111 of incubation buffer (10 mM Tris, 150 
mM NaCl, 2 mM EDTA) and incubated at 37°C for 1 hr. Incubation buffer (5 11l) was 
used as the blank. The LDL fraction was precipitated using 1 M heparin (25 111) 
containing 1 mg MnClz and kept on ice for 30 min. The radioactivity in the supernatant 
and the precipitate was counted and the results were expressed as percent cholesterol 
ester transferred/hour. 
2. 7 CETP mass 
CETP mass in plasma samples was quantitatively assayed using CETP ELISA-
DAIICHI kit (Daiichi Pure Chemicals Co., LTD, Tokyo). For the in vitro quantitative 
assay of CETP mass, plasma was diluted 120 times with dilution buffer (citrate buffer, 
pH 5.5). Sample (50 ) .tl) was added to the center of each microplate test well, coated with 
anti-CETP antibodies (anti-CETP MoAb). Dilution buffer (50 f.!l) was used as the blank. 
After 2 hrs of incubation at room temperature, the solution was removed from the wells, 
and the wells were thoroughly washed with the wash buffer (350 111 of phosphate buffer, 
pH 7.2). Anti CETP antibody conjugated with horse raddish peroxidase (anti-CETP 
MoAb HRP) (50 f.!l) was then added to each well and incubated for 1 hr at room 
temperature. After incubation, the solution was removed from the wells and the wells 
were washed thoroughly. Substrate solution (50 J.!l) containing a-phenylenediamine was 
then added to each well and incubated for 15 min at room temperature. Reaction was 
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stopped by adding stop regent (50 J.tl of7.7% H2S04). The intensity ofthe color that 
develops was read by Spectra Max 190 microplate reader at 492 nm. Concentration of 
the samples was calculated using a standard curve. 
2.8 LDL-receptor (LDLr) mRNA abundance 
All reagents for RNA isolation and RT-PCR were purchased from Invitrogen 
(Toronto, ON) unless otherwise stated. Total RNA from hamster livers was isolated 
using the FastRNA Kit, GREEN and the FastPrep FP120 instrument (Qbiogene, 
Carlsbad, CA) and stored at -20° C. The integrity of the RNA was checked by running 
the samples on a 1% agarose gel in borate buffer. Hepatic LDLr mRNA abundance was 
determined by reverse transcription and in vitro PCR amplification. Complementary 
DNA was synthesized from total liver RNA (2 J..lg) using Superscript™ II reverse 
transcriptase and used as templates for in vitro DNA amplification. LDLr and P-actin 
mRNA sequences were amplified using published sequences of specific primers (Bennett 
et al., 1995) (hamster LDLr sense 5' -TCGGTGACAA-TGTCGCACCAAG-3', antisense 
5 ' - GCTTCTGGT ACACTGGTTGTC-3'; hamster P-actin sense 5 '-
CATCGTACTCCTGCTTGCTG-3 ', antisense 5 '- GCTACAGCTTCAC-CACCACA-3 '). 
The PCR conditions were as follows; Initial heating up to 94° C, then 94° C for 1min, 55° 
C for 2 min and 72° C for 3 min for a total number of 30 cycles. The total number of 
cycles (30) for each PCR reaction was chosen to remain within the exponential phase of 
the reaction. The products were resolved on a 1.5% agarose gel (Figure 2.1). The 
representative bands were quantified using Chemilmager™ 4400 gel documentation 
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system (Alpha Inotech Corporation, San Leandro, CA). LDLr m-RNA expression was 
normalized against ~-actin m-RNA expression and expressed as relative units. 
2.9 Electron microcopy 
Electron microscopy was performed on LDL and VLDL fractions in order to 
assess the lipoprotein particle size. The lipoprotein fraction was applied to the carbon 
surface ofthe carbon coated copper grids (400 mesh, Marivac Ltd., QC) and incubated at 
room temperature for 5 minutes. The excess fluid was removed and samples were 
negatively stained using 2% phosphotungstic acid, pH 6.4 for 5 minutes (Anderson et al. 
1989). Grids were dried in air and lipoprotein particles were visualized using electron 
microscope type JEOL-JEM 1200 EX, at 30,000 magnification. 
2.10 Statistical analysis 
The effect of diet type (DT), dietary fat level (DL) and dietary cholesterol 
(CHOL) was determined using 3-way analysis ofvariance and a Tukey's post hoc test 
was used to test significant differences revealed by the ANOV A. Values are group 
means± SD, n=12; Differences were considered to be statistically significant if the 
associated P value was <0.05 (Steel and Torrie, 1980). 
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Figure 2.1 RT-PCR of LDL-receptor and ~-actin. Total RNA was reverse transcribed 
and eDNA amplified by PCR for LDL-receptor and ~-actin . Lane 1 shows 100 bp ladder 
(molecular marker); lane 2 shows the amplification in the absence of reverse 
transcriptase; lane 3 shows the amplification of hamster ~-actin in the presence of reverse 
transcriptase and lane 4 shows the amplification of hamster LDL-receptor in the presence 
of reverse transcriptase. 
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Chapter 3: Results 
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3.1 Body weights and Liver weights of hamsters 
The body weight and liver weight of hamsters fed low fat and high fat fish oil and 
MIX diets are given in table 3 .1 . There was no significant effect of dietary fat level or 
diet type on body weight gain. Diet type had no significant effect on liver weights both at 
low fat or high fat levels. There was a significant increase in liver weights in high fat 
diet fed hamsters compared to low fat diet fed hamsters irrespective of the diet type. 
However, food consumption measurements indicate no change in food intake in hamsters 
fed various diets 
3.2 Red Blood Cell (RBC) fatty acid composition 
RBC fatty acid composition was analyzed to confirm the incorporation of dietary 
fatty acids and is given in Table 3 .2. RBC from fish oil diet fed hamsters showed 
increased levels of EPA and DHA at the expense oflinoleic acid (18:2 n-6) and 
arachidonic acid (20:4 n-6) compared to MIX diet fed hamsters. Thus, the length of the 
experimental feeding period was sufficient to induce significant changes in the fatty acid 
composition of the tissues and these changes reflect dietary lipid intake. The extent of 
incorporation ofn-3 PUFA into RBC lipids was equivalent in both low fat diet groups 
and high fat diet groups irrespective of diet type. 
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Table 3.1: Body weight and liver weight of hamsters fed various diets. Hamsters 
were weighed at the beginning and conclusion of the experiment. The livers were 
collected and weighed at the conclusion of the experiment. Values shown are mean ± 
SD, n= 12 for each diet group. a, bMean values for liver weight with unlike superscript 
letters are significantly different. 
Fat 
Original body Final body Liver 
Diet type level% 
weight weight weight 
w/w 
(g) 
FO 5 101.18±3.67 95.6±5.45 3.40±0.24a 
FO+Chol 5 99.95±7.33 91.68±5.65 3.80±0.34a 
MIX 5 103.45±4.85 97.43±4.53 3.28±0.13a 
MIX+Chol 5 103. 70±6.45 96.53±6.87 3.85±0.40a 
FO 20 105.42±5.65 100.57±7.25 4.14±0.29b 
FO+Chol 20 104.47±3.37 97.97±3.87 4.44±0.47b 
MIX 20 108.10±5.98 108.43±4.95 4.35±0.48b 
MIX+Chol 20 107.27±4.73 107.55±4.01 5.12±0.84b 
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3.2 Red Blood Cell (RBC) fatty acid composition of hamsters fed various diets. 
Blood was centrifuged at 4° C at 3000 x g for 15 minutes. RBCs were collected (Bottom 
layer) and lipids were extracted using the method of Folch et al. (1957). Fatty acid 
composition was determined by gas liquid chromatography. n= 12 for each diet group. 
Abbreviations used: FO. Fish oil diet; MIX, MIX diet; ND, not detected. 
Dietary Groups 
Fatty Acid F05% MIX5% F020% MIX20% 
14:0 0.7 0.4 1.7 0.4 
16:0 24.3 25.0 24.0 25.0 
16:1n7 3.1 1.6 5.4 ND 
18:0 9.4 10.26 9.5 11.3 
18:1 20.0 19.0 19.2 18.2 
18:2n6 8.06 17.2 5.2 22.8 
20:4n6 8.6 10.3 6.0 9.1 
20:5n3 6.5 1.0 10.9 0.9 
22:4n6 0.7 1.1 0.5 0.8 
22:5n3 2.6 2.1 2.0 0.9 
22:6n3 12.7 5.5 12.3 6.8 
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3.3 Effect of dietary fats on plasma lipid profile 
3.3.1 Effect of diet type on plasma lipids 
The plasma lipid composition (total cholesterol, free cholesterol, cholesterol ester and 
triacylglycerol) ofhamsters fed various diets is shown in Figure 3.1-3.4. The hamsters 
fed fish oil diet had significantly higher levels of plasma total cholesterol, free 
cholesterol, cholesterol ester and triacylglycerol compared to hamsters fed a MIX diet. 
3.3.2 Effect of dietary fat level on plasma lipid profile 
Irrespective of the diet type, hamsters fed the high fat diets had significantly 
higher levels of total cholesterol, free cholesterol, cholesterol ester and triacylglycerol 
concentrations compared to hamsters fed the low fat diets. However, this hyperlipidemic 
effect of dietary fat level was greater in hamsters fed the fish oil dief(DT X DL 
interaction, p= 0.0001). 
3.3.3 Effect of addition of cholesterol to diets on plasma lipid profile 
Addition of cholesterol to the diets showed an increase in plasma total cholesterol, 
free cholesterol, cholesterol ester and triacylglycerol concentrations in both fish oil and 
MIX diet fed hamsters (Figure 3.1-3.4). However, this increase is prominent in fish oil 
diet fed hamsters (DT X CHOL interaction, p= 0.0003, < 0.03, < 0.002, p< 0.03 
respectively). Furthermore, the effect of dietary cholesterol on plasma total cholesterol, 
cholesterol ester and triacylglycerol concentrations was greater in high fat diet fed 
hamsters compared to low fat diet fed hamsters (DL X CHOL interaction, p< 0.02). 
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Figure 3.1: Plasma free cholesterol concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet, (FO) or a MIX diet at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. The free cholesterol concentration was analyzed as described in the 
methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.3: 3-way ANOV A results for plasma total cholesterol concentrations. 
Source F-Value P-Value 
Diet type 121.177 0.0001 
Diet level 125.992 0.0001 
Cholesterol 36.258 0.0001 
Diet type* diet level 90.587 0.0001 
Diet type * cholesterol 16.160 0.0003 
Diet level * cholesterol 12.556 0.0012 
Diet type * diet level * cholesterol 9.406 0.0042 
46 
18 
16 
-
14 c 
I. 12 ~-
--
til;:;;; 
~ c 10 0 8 
-5 8 8 
~- 6 ~ 
lor 
~ 4 
2 
0 
FOS% MIXS% F020% MIX20% 
Figure 3.2: Plasma free cholesterol concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of 0.25% w/w 
cholesterol. The free cholesterol concentration was analyzed as described in the 
methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.4: 3-way ANOV A results for plasma free cholesterol concentrations. 
Source F-Value P-Value 
Diet type 42.047 0.0001 
Diet level 23.896 0.0001 
Cholesterol 5.535 0.0244 
Diet type * diet level 34.686 0.0001 
Diet type * cholesterol 5.638 0.0232 
Diet level * cholesterol 0.769 0.3866 
Diet type* diet level* cholesterol 4.180 0.0485 
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Figure 3.3: Plasma cholesterol ester concentrations of hamsters fed 
various diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 
20% w/w fat level, in the absence (hatched bars) or presence (solid bars) of 
0.25% w/w cholesterol. Cholesterol ester concentration was calculated as 
described in the methods. Differences between groups were evaluated using 3-
way ANOV A. Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.5: 3-way ANOV A results for plasma cholesterol ester concentrations. 
Source F-Value P-Value 
Diet type 120.991 0.0001 
Diet level 137.628 0.0001 
Cholesterol 41.483 0.0001 
Diet type * diet level 93.455 0.0001 
Diet type* cholesterol 12.368 0.0012 
Diet level * cholesterol 11.176 0.0020 
Diet type * diet level * cholesterol 7.776 0.0085 
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Figure 3.4: Plasma triacylglycerol concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Triacylglycerol concentration was analyzed as described in the 
methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.6: 3-way ANOV A results for plasma total triacylglycerol concentrations. · 
Source F-Value P-Value 
Diet type 52.558 0.0001 
Diet level 56.466 0.0001 
Cholesterol 11.585 0.0019 
Diet type * diet level 44.093 0.0001 
Diet type * cholesterol 5.751 0.0227 
Diet level * cholesterol 7.236 0.0114 
Diet type * diet level * cholesterol 3.660 0.0650 
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3.4 Effect ofdietary fats on lipoprotein lipid profile 
The hamsters fed a high fat fish oil diet (20% w/w) had milky plasma which 
contained very high levels of chylomicron like particles, which were rich in cholesterol 
(Figure 3.5) and triacylglycerols (Figure 3.6), irrespective of absence or presence of 
cholesterol. 
3.4.1 Effect of dietary fats on VLDL lipids 
3.4.1.1 Effect of diet type on VLDL lipids 
Marked differences in VLDL composition were seen in hamsters fed the different 
diets (Figure 3. 7 -3.11). There was a significant increase in VLDL total cholesterol, free 
cholesterol, cholesterol ester, triacylglycerol and phospholipid concentrations in fish oil 
diet fed hamsters compared to MIX diet fed hamsters. 
3.4.1.2 Effect of dietary fat level on VLDL lipids 
Increasing the dietary fat level from low fat to high fat resulted in a significant 
increase in VLDL total cholesterol, free cholesterol, cholesterol ester, triacylglycerol and 
phospholipid concentrations in both fish oil and MIX diet fed hamsters (Figure 3.7-3.1 1). 
This dietary fat level dependent increase was greater in fish oil diet fed hamsters 
compared to MIX diet fed hamsters (DT X DL interactions, p= 0.0001, 0.0001, 0.0001 , 
0.02 respectively). 
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Figure 3.5: Chylomicron total cholesterol concentrations of hamsters fed 
high fat fish oil diets. Hamsters fed a high fat fish oil diet had milky plasma due 
to chylomicron like particles. This fraction was separated and total cholesterol 
concentration was analyzed as described in methods. Differences between groups 
were evaluated using Student's t test. Abbreviations used: FO, fish oil diet; Chol, 
cholesterol. 
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Figure 3.6: Chylomicron triacylglycerolconcentrations of hamsters fed 
high fat fish oil diets. Hamsters fed a high fat fish oil diet had milky plasma due 
to chylomicron like particles. This fraction was separated and total cholesterol 
concentration was analyzed as described in methods. Differences between groups 
were evaluated using Student's t test. Abbreviations used: FO, fish oil diet; Chol, 
cholesterol. 
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3.4.1.3 Effect of addition of cholesterol to the diets on VLDL lipids 
Dietary supplementation of cholesterol resulted in an increase in VLDL total 
cholesterol, cholesterol ester and triacylglycerol concentrations in both fish oil and MIX 
diet fed hamsters (Figure 3.7-3.10). Dietary-cholesterol induced increase in VLDL 
cholesterol ester concentration was prominent in fish oil diet fed hamsters compared 
to MIX diet fed hamster (DT X CHOL interaction, p< 0.006). There was no effect of 
dietary fat level on dietary cholesterol-induced changes in VLDL cholesterol or 
triacylglycerol concentrations. 
3.4.2 Effect of dietary fats on LDL lipids 
3.4.2.1 Effect of diet type on LDL lipids 
The LDL lipid composition is shown in Figure 3.12-3.16. LDL from fish oil diet 
fed hamsters showed significantly higher concentrations of total cholesterol, cholesterol 
ester, triacylglycerol and phospholipid compared to MIX diet fed hamsters. However, 
the trend of increase in free cholesterol concentrations in fish oil diet fed hamsters was 
not significant. 
3.4.2.2 Effect of dietary fat level on LDL lipids 
Increasing the dietary fat level of fish oil from low fat to high fat caused a 
significant increase in LDL free cholesterol (p< 0.0001), triacylglycerol (DT X DL 
interaction, p<0.0001) and phospholipid concentrations (p=0.0001), however, a 
significant decrease in LDL total cholesterol and cholesterol ester concentrations was 
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Figure 3.7: VLDL total cholesterol concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat, level in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Total cholesterol concentration was analyzed as described in the 
methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.7: 3-way ANOVA results for VLDL total cholesterol concentrations. 
Source F-Value :P-Value 
Diet type 73.689 0.0001 
Diet level 54.352 0.0001 
Cholesterol 12.409 0.0015 
Diet type * diet level 36.298 0.0001 
Diet type * cholesterol 3.618 0.0675 
Diet level * cholesterol 0.396 0.5345 
Diet type * diet level * cholesterol 0.057 0.8126 
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Figure 3.8: Changes in VLDL free cholesterol concentrations of hamsters fed 
various diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 
20% w/w fat level, in the absence (hatched bars) or presence (solid bars) of 
0.25% w/w cholesterol. The free cholesterol concentration was analyzed as 
described in the methods. Differences between groups were evaluated using 
3-way ANOV A. Only significantly different comparisons (p< 0.05) are indicated 
in the figure. Values are means for 12 animals with SD shown by vertical bars. 
59 
Table 3.8: 3-way ANOV A results for VLDL free cholesterol concentrations. 
Source F-Value P-Value 
Diet type 88.220 0.0001 
Diet level 92.254 0.0001 
Cholesterol 0.153 0.6986 
Diet type * diet level · 70.916 0.0001 
Diet type * cholesterol 1.136 0.2944 
Diet level * cholesterol 1.147 0.2923 
Diet type * diet level * cholesterol 2.717 0.1091 
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Figure 3.9: VLDL cholesterol ester concentrations of hamsters fed 
various diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 
20% w/w fat level, in the absence (hatched bars) or presence (solid bars) of 
0.25% w/w cholesterol. Cholesterol ester concentration was calculated as 
described in the methods. Differences between groups were evaluated using 3-
way ANOV A. Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.9: 3-way ANOV A results for VLDL cholesterol ester concentrations . 
. . 
Source F-Value P-Value 
Diet type 66.882 6.0001 
Diet level 44.269 0.0001 
Cholesterol 21 .548 0.0001 
Diet type * diet level 29.317 0.0001 
Diet type * cholesterol 9.144 0.0053 
Diet level * cholesterol 1.774 0. 1936 
Diet type * diet level * cholesterol 0.168 0.6849 
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Figure 3.10: VLDL triacylglycerol concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Triacylglycerol concentration was analyzed as described in the 
methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.10: 3-way ANOVA results for VLDL triacylglycerol concentrations. 
Source F-Value P-Value 
Diet type 18.634 0.0002 
Diet level 26.054 0.0001 
Cholesterol 4.425 0.0457 
Diet type * diet level 7.537 0.0110 
Diet type* cholesterol 0.001 0.9707 
Diet level * cholesterol 0.914 0.3481 
Diet type * diet level * cholesterol 1.407 0.2467 
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Figure 3.11: VLDL phospholipid concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Phospholipid concentration was assayed as described in the methods. 
Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.11: 3-way ANOVA results for VLDL phospholipid concentrations. 
Source F-Value P-Value 
Diet type 282.180 0.0001 
Diet level 230.102 0.0001 
Cholesterol 0.017 0.8985 
Diet type * diet level 146.681 0.0001 
Diet type * cholesterol 20.899 0.0001 
Diet level * cholesterol 27.800 0.0001 
Diet type * diet level * cholesterol 61.734 0.0001 
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observed (DT X DL interaction, p< 0.002, 0.03 respectively). There was no effect of 
dietary fat level on LDL total cholesterol, cholesterol ester or triacylglycerol 
concentrations in MIX diet fed hamsters. 
3.4.2.3 Effect of addition of cholesterol to the diets on LDL lipids 
Cholesterol supplementation to fish oil diet resulted in an increase in LDL total 
cholesterol (DT X CHOL interaction, p= 0.0007), cholesterol ester (p= 0.0001) and 
phospholipid (DT X CHOL interaction, p= 0.009) concentrations (Figure 3.12-3.16). 
Dietary cholesterol-induced increase in LDL triacylglycerol concentration was observed 
only in low fat fish oil diet fed hamsters (DL X CHOL interaction, p< 0.02). 
Furthermore, the effect of dietary cholesterol was greater in low fat fish oil diet fed 
hamsters with respect of total cholesterol (DT X DL X CHOL interaction, p< 0.004) and 
cholesterol ester (DL X CHOL interaction, p= 0.0004) concentrations. There was no 
effect of dietary cholesterol amount on LDL lipids in MIX diet fed hamsters. 
3.4.3 Effect of dietary fats on HDL lipids 
3.4.3.1 Effect of diet type on HDL lipids 
Changes in HDL lipid composition are given in (Figure 3.1 7-3.21). Fish oil diet 
fed hamsters had significantly lower concentrations ofHDL total cholesterol, free 
cholesterol, cholesterol ester and phospholipid concentrations compared to MIX diet fed 
hamsters. However, there was no significant effect offish oil on HDL triacylglycerol 
concentrations. 
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Figure 3.12: LDL total cholesterol concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Total cholesterol concentration was analyzed as described in the 
methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.12: 3-way ANOV A results for LDL total cholesterol concentrations. 
Source F-Value P-Value 
Diet type 205.346 0.0001 
Diet level 9.300 0.0052 
Cholesterol 13.125 0.0012 
Diet type * diet level 12.652 0.0015 
Diet type * cholesterol 14.797 0.0007 
Diet level * cholesterol 6.335 0.0183 
Diet type * diet level * cholesterol 10.184 0.0037 
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Figure 3.13: Changes in LDL free cholesterol concentrations of hamsters fed 
various diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 
20% w/w fat level, in the absence (hatched bars) or presence (solid bars) of 
0.25% w/w cholesterol. Free cholesterol concentration was analyzed as described 
in the methods. Differences between groups were evaluated using 3-way 
ANOV A. Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.13: 3-way ANOV A results for LDL free cholesterol concentrations. 
Source F-Value P-Value 
Diet type 2.742 0.1087 
Diet level 82.731 0.0001 
Cholesterol 2.124 0. 1551 
Diet type * diet level 0.029 0.8665 
Diet type* cholesterol 1.472 0.2342 
Diet level * cholesterol 0.034 0.8546 
Diet type * diet level * cholesterol 0.407 0.5284 
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Figure 3.14: LDL cholesterol ester concentrations of hamsters fed 
various diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 
20% w/w fat level, in the absence (hatched bars) or presence (solid bars) of 
0.25% w/w cholesterol. Cholesterol ester concentration was calculated as 
described in the methods. Differences between groups were evaluated using 3-
way ANOV A. Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.14: 3-way ANOV A results for LDL cholesterol ester concentrations. 
Source F-Value P-Value 
Diet type 19.273 0.0001 
Diet level 46.008 0.0001 
Cholesterol 20.807 0.0001 
Diet type * diet level 5.340 0.0279 
Diet type* cholesterol 2.800 0.1046 
Diet level * cholesterol 15.556 0.0004 
Diet type * diet level * cholesterol 1.042 0.3154 
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Figure 3.15: LDL triacylglycerol concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Triacylglycerol concentration was analyzed as described in the 
methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.15: 3-way ANOV A results for LDL triacylglycerol concentrations. 
Source F-Value P-Value 
Diet type 358.713 0.0001 
Diet level 44.572 0.0001 
Cholesterol 1.652 0.2086 
Diet type * diet level 62.868 0.0001 
Diet type * cholesterol 1.708 0.2011 
Diet level * cholesterol 7.442 0.0105 
Diet type * diet level * cholesterol 2.799 0.1047 
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Figure 3.16: LDL phospholipid concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of 0.25% w/w 
cholesterol. Phospholipid concentration was assayed as described in the methods. 
Differences between groups were evaluated using 3-way ANOV A. Values are 
means for 12 animals with SD shown by vertical bars. 
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Table 3.16: 3-way ANOVA results for LDL phospholipid concentrations. 
Source F-Value P-Value 
Diet type 135.799 0.0001 
Diet level 3.431 0.0754 
Cholesterol 4.957 0.0349 
Diet type * diet level 4.999 0.0342 
Diet type * cholesterol 7.980 0.0090 
Diet level * cholesterol 1.707 0.2029 
Diet type * diet level * cholesterol 3.628 0.0679 
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3.4.3.2 Effect of dietary fat level on HDL lipids 
Increasing the dietary fat level from low fat to high fat resulted in a decrease in 
HDL total cholesterol, cholesterol ester and phospholipid concentrations in fish oil diet 
fed hamsters (DT X DL interaction, p= 0.0005) and an increase in these parameters in 
MIX diet fed hamsters (Figure 3.17-3.21). Furthermore, there was dietary fat level 
dependent increase in HDL triacylglycerol concentration in fish oil diet fed hamsters (DT 
X DL interaction, p< 0.04). 
3.4.3.3 Influence of addition of cholesterol to the diets on HDL lipids 
Cholesterol supplementation to diets resulted in an increase in HDL total 
cholesterol, cholesterol ester and phospholipid concentrations irrespective of diet type 
(Figure 3.17-3.21). However, there was no consistent effect of cholesterol 
supplementation on HDL triacylglycerol concentrations. 
3.5 Effect of dietary fats on hepatic lipid composition 
3.5.1 Effect of diet type on hepatic lipids 
Changes in hepatic lipid composition are shown in Figure 3.22-3.25. Hamsters fed a low 
fat fish oil diet show lower hepatic total cholesterol, cholesterol ester and triacylglycerol 
levels compared to hamsters fed a low fat MIX diet. In contrast, high fat fish oil diet fed 
hamsters show significantly higher levels of total cholesterol, cholesterol esters and 
triacylglycerols compared to high fat MIX diet fed hamsters (DT X DL interaction, p< 
0.0001). There was no significant difference in free cholesterol levels between two 
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Figure 3.17: HDL total cholesterol concentrations of hamsters fed 
various diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 
20% wlw fat level, in the absence (hatched bars) or presence (solid bars) of 
0.25% w/w cholesterol. Total cholesterol concentration was analyzed as 
described in the methods. Differences between groups were evaluated using 3-
way ANOV A. Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.17: 3-way ANOV A results for HDL total cholesterol concentrations. 
Source F-Value P-Value 
Diet typ"e 150.815 0.0001 
Diet level 0.393 0.5385 
Cholesterol 11.917 0.0018 
Diet type* diet level 20.343 0.0001 
Diet type* cholesterol 1.062 0:3116 
Diet level * cholesterol 2.147 0.1540 
Diet type * diet level * cholesterol 0.602 0.4445 
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Figure 3.18: Changes in HDL free cholesterol concentrations of hamsters fed 
various diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 
20% w/w fat level, in the absence (hatched bars) or presence (solid bars) of 
0.25% w/w cholesterol. Free cholesterol concentration was analyzed as described 
in the methods. Differences between groups were evaluated using 3-way 
ANOVA. Values are means for 12 animals with SD shown by vertical bars. 
81 
Table 3.18: 3-way ANOV A results for HDL free cholesterol concentrations. 
Source F-Value P-Value 
Diet type 66.224 0.0001 
Diet level 0.102 0.7517 
Cholesterol 0.409 0.5278 
Diet type * diet level 0.395 0.5350 
Diet type * cholesterol 0.075 0.7859 
Diet level * cholesterol 1.160 0.2911 
Diet type * diet level * cholesterol 1.700 0.2033 
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Figure 3.19: Effect of various diets on HDL cholesterol ester Concentrations. 
Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% w/w fat 
level, in the absence (hatched bars) or presence (solid bars) of 0.25% w/w 
cholesterol. Cholesterol ester concentration was calculated as described in the 
methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.19: 3-way ANOV A results for HDL cholesterol ester concentrations. 
Source F-Value P-Value 
Diet tyPe 56.626 0.0001 
Diet level 2.587 0.1173 
Cholesterol 13.300 0.0009 
Diet type* diet level 25.002 0.0001 
Diet type* cholesterol 0.224 0.6390 
Diet level * cholesterol 1.106 0.3005 
Diet type* diet level* cholesterol 2.689 0.1105 
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Figure 3.20: HDL triacylglyceroJ concentrations of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Triacylglycerol concentration was analyzed as described in the 
methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 12 animals with SD shown by vertical bars. 
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Table 3.20: 3-way ANOV A results for HDL triacylglycerol concentrations. 
Source F-Value P-Value 
Diet type 1.201 0.2810 
Diet level 0.939 0.3395 
Cholesterol 0.194 0.6624 
Diet type * diet level 4.825 0.0352 
Diet type* cholesterol 0.064 0.8017 
Diet level * cholesterol 4.643 0.0386 
Diet type * diet level * cholesterol 0.666 0.4204 
86 
6 
5 
<'-l 
"0 4 
·--l:l.,- I .... ~ 
- Q I j e 3 l:l.S ~-
..:: 2 
=--
1 
0 
FOS% MIXS% F020% MIX20% 
Figure 3.21: HDL phospholipid concentrations of hamsters fed various diets. 
Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% w/w fat 
level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Phospholipid concentration was assayed as described in the methods. 
Differences between groups were evaluated using 3-way ANOV A. Values are 
means for 12 animals with SD shown by vertical bars. 
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Table 3.21: 3-way ANOV A results for HDL phospholipid concentrations. 
Source F-Value P-Value 
Diet type 314.690 0.0001 
Diet level 7.924 0.0101 
Cholesterol 18.854 0.0003 
Diet type * diet level 16.319 0.0005 
Diet type * cholesterol 4.280 0.0505 
Diet level * cholesterol 15.549 0.0007 
Diet type * diet level * cholesterol 28.213 0.0001 
88 
diet types (Figure 3.23). 
3.5.2 Effect of amount of fat on hepatic lipids 
Increasing the dietary fat level from low fat (5% w/w) to high fat (20% w/w) in 
fish oil diet fed hamsters resulted in an increase in hepatic total cholesterol, cholesterol 
ester and triacylglycerol concentrations (DT X DL interaction, p< 0.0001) while there 
was no effect on free cholesterol concentrations (Figure 3.22-3.25). However, increasing 
the fat level in MIX diet fed hamsters did not have any effect on hepatic levels of total 
cholesterol, cholesterol ester and triacylglycerol. 
3.5.3 Effect of cholesterol supplementation on hepatic lipids 
Addition of cholesterol to the diets increased hepatic total cholesterol and 
cholesterol ester concentrations (Figure 3.22 and 3.24). However, this effect was 
prominent in fish oil diet fed hamsters compared to MIX diet fed hamsters (DT X DL 
interaction, p< 0.05). Further more, only fish oil diet fed hamsters showed a dietary 
cholesterol-induced elevation ofhepatic triacylglycerollevels (DT X CHOL interaction, 
p< 0.03). In addition, the effect of dietary cholesterol on hepatic cholesterol ester levels 
was greater in low fat diet fed hamsters (DL X CHOL interaction, p< 0.03) compared to 
high fat diet fed hamsters. 
3.6 Influence of dietary fat on hepatic MTTP activity 
Hepatic MTTP activity of hamsters fed various diets is given in Figure 3.26. 
There was no significant difference in MTTP activity between low fat fish oil and MIX 
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Figure 3.22: Hepatic total cholesterol concentration of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Lipids were extracted from liver samples and total cholesterol level 
was analyzed as described in the methods. Differences between groups were 
evaluated using 3-way ANOV A. Values are means for 12 animals with SD 
shown by vertical bars. 
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Table 3.22: 3-way ANOV A results for hepatic total cholesterol concentrations. 
Source F-Value P-Value 
Diet type 6.518 0.0148 
Diet level 0.060 0.8072 
Cholesterol 15.217 0.0004 
Diet type * diet level 21.339 0.0001 
Diet type * cholesterol 4.098 0.0500 
Diet level * cholesterol 2.846 0.0998 
Diet type * diet level * cholesterol 0.275 0.6028 
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Figure 3.23: Hepatic free cholesterol concentration of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of 0.25% w/w 
cholesterol. Lipids were extracted from liver samples and free cholesterol level 
was analyzed as described in the methods. Differences between groups were 
evaluated using 3-way ANOV A. Values are means for 12 animals with SD 
shown by vertical bars. 
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Table 23: 3-way ANOVA results for hepatic free cholesterol concentrations. 
Source F-Value P-Value 
Diet type 2.914 0.0960 
Diet level 2.804 0.1022 
Cholesterol 0.020 0.8879 
Diet type * diet level 0.010 0.9198 
Diet type * cholesterol 0.030 0.8625 
Diet level * cholesterol 3.996 0.0528 
Diet type * diet level * cholesterol 2.119 0.1537 
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Figure 3.24: Effect of various diets on hepatic cholesterol ester concentration. 
Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% w/w fat 
level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Lipids were extracted from liver samples and cholesterol ester level 
was calculated as described in the methods. Differences between groups were 
evaluated using 3-way ANOV A. Values are means for 12 animals with SD 
shown by vertical bars. 
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Table 3.24: 3-way ANOV A results for hepatic cholesterol ester concentrations 
Source F-Value P-Value 
Diet type 4.884 0.0332 
Diet level 0.031 0.8609 
Cholesterol 17.855 0.0001 
Diet type * diet level 24.251 0.0001 
Diet type * cholesterol 4.284 0.0453 
Diet level * cholesterol 5.749 0.0215 
Diet type * diet level * cholesterol 0.037 0.8485 
95 
16 
14 
-
12 
~ 
"" 10 Q# CJ~ ~bll 8 
~El 
6 CJ-c: 
.... 
"" 4 E-; 
2 
0 
FOS% MIXS% F020% MIX20% 
Figure 3.25: Hepatic triacylglycerol concentration of hamsters fed various 
diets. Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% 
w/w fat level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Lipids were extracted from liver samples and triacylglycerollevel 
was analyzed as outlined in the methods. Differences between groups were 
evaluated using 3-way ANOV A. Values are means for 12 animals with SD 
shown by vertical bars. 
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Table 3.25: 3-way ANOV A results for hepatic triacylglycerol concentrations. 
Source F-Value P-Value 
Diet type 15.893 0.0003 
Diet level 55.271 0.0001 
Cholesterol 1.046 0.3135 
Diet type * diet level 26.569 0.0001 
Diet type * cholesterol 5.562 0.0241 
Diet level * cholesterol 0.009 0.9248 
Diet type * diet level * cholesterol 0.672 0.4181 
97 
diet fed hamsters. However, hamsters fed a high fat fish oil diet show a significant 
increase in MTTP activity compared to high fat MIX diet fed hamsters (DT X DL 
interaction, p< 0.05). Dietary fat level had no effect on MTTP activity. Addition of 
cholesterol to the low fat fish oil diet resulted in an increase in MTTP activity. 
3. 7 Effect of dietary fats on adipose tissue LPL activity 
The adipose tissue LPL activity of hamsters fed various diets is given in figure 
3.28. There was a trend of increase in LPL activity in fish oil diet fed hamsters 
compared to MIX diet fed hamsters. In general, dietary supplementation of cholesterol 
had no effect on LPL activity, but hamsters fed low fat fish oil diet showed dietary 
cholesterol dependent decrease in LPL activity (DT X CHOL and DL X CHOL 
interactions, p< 0.0004). 
3.8 Effect of dietary fat on plasma CETP activity and CETP mass 
Changes in CETP activity and CETP mass are shown in Figure 3.28 and 3.29 
respectively. The CETP activity and the CETP mass were significantly lower in hamsters 
fed the fish oil diet compared to MIX diet fed hamsters. Increasing the dietary fat level 
from low fat to high fat caused a decrease in CETP mass in fish oil diet fed hamsters 
whereas, an increase in MIX diet fed hamsters (DT X DL interaction, p< 0.002). 
However, there was no effect of dietary fat level on plasma CETP activity in both fish oil 
and MIX diet fed hamsters. 
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Figure 3.26: Effect of various diets on hepatic MTTP activity. Hamsters were 
fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% w/w fat level, in the 
absence (hatched bars) or presence (solid bars) of0.25% w/w cholesterol. MTTP 
activity of liver homogenate was assayed as described in the methods. 
Differences between groups were evaluated using 3-way ANOV A. Values are 
means for 12 animals with SD shown by vertical bars. 
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Table 3.26: 3-way ANOV A results for MTTP activity. 
Source F-Value P-Value 
Diet type 5.125 0.0305 
Diet level 0.289 0.5946 
Cholesterol 7.139 0.0118 
Diet type * diet level 4.207 0.0485 
Diet type * cholesterol 0.018 0.8933 
Diet level * cholesterol 2.145 0.1528 
Diet type * diet level * cholesterol 1.147 0.2921 
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Figure 3.27: Adipose tissue LPL activity in various diet fed hamsters. 
Hamsters were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% w/w fat 
level, in the absence (hatched bars) or presence (solid bars) of0.25% w/w 
cholesterol. Adipose tissue was collected and LPL activity was assayed as 
described in the method section. Differences between groups were evaluated 
using 3-way ANOV A. Values are means for 12 animals with SD shown by 
vertical bars. 
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Table 3.27: 3-way ANOV A results for adipose tissue LPL activity. 
Source F-Value P-Value 
Diet type 2.593 0.1269 
Diet level 7.923 0.0125 
Cholesterol 1.095 0.3109 
Diet type * diet level 1.844 0.1934 
Diet type * cholesterol 22.926 0.0002 
Diet level * cholesterol 19.982 0.0004 
Diet type* diet level* cholesterol 1.028 0.3258 
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Supplementation of cholesterol to diets showed an increase in CETP activity and 
CETP mass in both fish oil and MIX diet fed hamsters. Furthermore, the effect of dietary 
cholesterol on plasma CETP activity was prominent in low fat diet fed hamsters (DL X 
CHOL interaction, p< 0.0001). 
3.9 Effect of dietary fat on hepatic LDLr mRNA expression 
The LDLr mRNA expression is shown in Figure 3.30. There was a significant 
reduction in hepatic LDLr mRNA expression in fish oil diet fed hamsters compared to 
MIX diet fed hamsters. Increasing the dietary fat level show a significant reduction in 
LDLr mRNA expression in fish oil diet fed hamsters (p< 0.001). 
Dietary cholesterol supplementation had no effect on LDLr mRNA expression in 
fish oil diet fed hamsters, whereas supplementation of cholesterol to the MIX diet 
reduced the LDLr mRNA expression (DT X CHOL interaction, p< 0.0001) 
3.10 Influence of dietary fat on lipoprotein particle size 
3.10.1 LDL particle size 
The average particle size ofLDL from hamsters fed the fish oil diet was larger 
compared to hamsters fed the MIX diet (Figure 3.32). The average particle size is 
approximately 7nm in the MIX diet groups and approximately 15nm in the fish oil fed 
groups (n= 3 for each diet group). The amount of fat in the diet had no significant effect 
on LDL particle size (data not shown). The ratio ofLDL surface lipids (free cholesterol 
and phospholipids) to core lipids (cholesterol esters and triacylglycerols) was lower 
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Figure 3.28: Plasma CETP activity of hamsters fed various diets. Hamsters 
were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% w/w fat level, in 
the absence (hatched bars) or presence (solid bars) of0.25% w/w cholesterol. 
Plasma was collected and assayed for CETP activity using the radioisotope 
method as described in the methods. Differences between groups were evaluated 
using 3-way ANOV A. Values are means for 12 animals with SD shown by 
vertical bars. 
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Table 3.28: 3-way ANOV A results for plasma CETP activity. 
Source F-Value P-Value 
Diet type 12.538 0.0015 
Diet level 0.110 0.7429 
Cholesterol 43.341 0.0001 
Diet type * diet level 1.210 0.2815 
Diet type* cholesterol 0.587 0.4505 
Diet level * cholesterol 27.181 0.0001 
Diet type * diet level * cholesterol 6.974 0.0138 
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Figure 3.29: Plasma CETP mass of hamsters fed various diets. Hamsters 
were fed a fish oil diet (FO) or a MIX diet, at 5% w/w or 20% w/w fat level, in 
the absence (hatched bars) or presence (solid bars) of0.25% w/w cholesterol. 
Plasma was collected and assayed for CETP mass using ELISA as described in 
the methods. Differences between groups were evaluated using 3-way ANOV A. 
Values are means for 4 animals with SD shown by vertical bars. 
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Table 3.29: 3-way ANOV A results for plasma CETP mass. 
Source F-Value P-Value 
Diet type 81.932 0.0001 
Diet level 1.339 0.2642 
Cholesterol 22.183 0.0002 
Diet type * diet level 15.148 0.0013 
Diet type * cholesterol 0.388 0.5419 
Diet level * cholesterol ·o.o79 0.7820 
Diet type * diet level * cholesterol 3.188 0.0931 
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Figure 3.30: LDL-receptor gene expression of hamsters fed various diets .. 
Hamsters were fed a fish oil diet or a MIX diet, at 5% w/w or 20% w/w fat level, 
in the absence (hatched bars) or presence (solid bars) of0.25% w/w cholesterol. 
Total liver RNA was extracted, reverse transcribed and the eDNA template for 
hamster LDL-receptor and hamster ~-actin was amplified as described in the 
method section. The amounts of amplified templates were quantified and the 
abundance of LDLr mRNA is expressed relative to ~-actin mRNA content. 
Differences between groups were evaluated using 3-way ANOV A. Values are 
means for 12 animals with SD shown by vertical bars. 
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Table 3.30: ANOV A results for LDLr mRNA abundance. 
Source F-Value P-Value 
Diet type 11.587 0.0036 
Diet level 15.949 0.0010 
Cholesterol 11.77 0.0034 
Diet type * diet level 0.162 0.6930 
Diet type * cholesterol 25.934 0.0001 
Diet level * cholesterol 0.011 0.9160 
Diet type * diet level * cholesterol 2.095 0.1671 
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in fish oil fed hamsters (0.36 at low fat level and 0.46 at high fat level) compared to 
hamsters fed the MIX diet (0.85 at low fat level and 1.16 at high fat level) (Table 3.32). 
3.10.2 VLDL particle size 
The average particle size of VLDL from hamsters fed fish oil diet was smaller compared 
to hamsters fed the MIX diet (Figure 3.33). The particle size ofVLDL from fish oil fed 
hamsters was 33 nm, whereas the VLDL particle size from MIX diet fed hamsters was 60 
nm (n= 3 for each group). The amount of fat in the diet had no significant effect on 
VLDL particle size (data not shown 
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Figure 3.31: The effect of dietary fish oil on LDL particle size. Purified 
LDL fractions (d<l.065) were negatively stained as explained in methods and 
electron microscopy was performed at 80 KV. Panel A shows the LDL particles 
of fish oil· fed hamsters and panel B shows the particles of MIX diet fed hamsters. 
Magnification is x 180. Bar=lOO nm. 
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Table 3.32: Surface lipid to Core lipid ratio ofLDL particles from hamsters fed 
various diets. Surface lipids are composed of free cholesterol and phospholipids. Core 
lipids are composed of cholesterol esters and triacylglycerols. The surface lipid to core 
lipid ratio ofLDL-particles was calculated by dividing the surface lipid concentration by 
the core lipid concentration of LDL. Differences between groups were evaluated using 
Student's t test. Values shown are mean± SD, n= 12 for each diet group. a, bMean values 
with unlike superscript letters are significantly different. 
Fish oil MIX 
Fat level 
- Cholesterol + Cholesterol -Cholesterol + Cholesterol 
(Surface lipid: core lipid) (Surface lipid: core lipid) 
Mean SD Mean SD Mean SD Mean SD 
5% 0.43a 0.12 0.31a 0.05 0.81b 0.32 0.82b 0.10 
20% 0.45a 0.08 0.47a 0.18 1.04b 0.35 0.99b 0.35 
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Figure 3.32: The effect of dietary fish on on VLDL particle size. VLDL 
fractions (d<l.065) were negatively stained as explained in methods and electron 
microscopy was performed at 80 KV. Panel A shows the VLDL particles of fish 
oil fed hamsters and panel B shows the particles of MIX diet fed hamsters. 
Magnification is x 180. Bar=200 nm. 
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Chapter 4: Discussion 
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4.1 Effect of fish oil on plasma and lipoprotein lipids 
Many studies have shown that fish oil suppresses plasma triacylglycerol 
concentrations (Wong et al., 1984, Surette et al., 1992b). Furthermore it has been 
observed that this hypotriglyceridemic effect of fish oil is dose dependent (Sanders et al., 
1983, Blonk et al., 1990). However, the effect offish oil on plasma cholesterol 
concentration is inconsistent. Human subjects with type-2 diabetes mellitus or 
dyslipidemia show a significant increase in LDL-cholesterol concentration following a 
high fat fish oil diet. Our study was designed to determine the effect of fish oil on plasma 
and lipoprotein lipid composition under different dietary fat levels and the regulation of 
metabolic pathways involved in lipoprotein lipid metabolism. We examined these effects 
offish oil at low (5% w/w) and high fat (20% w/w) levels with or without added 
cholesterol (0.25% w/w) using the F1B hamster as the animal model because of the 
similarity of its lipid profile to humans and their high susceptibility to diet-induced 
hyperlipidemia (Kowala et al., 1991, Trautwein et al., 1993). The proportions ofPUFA, 
MUF A and saturated fatty acids in the control diet (MIX diet) was kept similar to the fish 
oil diet by using a mixture oflard and safflower oil (1.5: 1), thus the main difference in 
the diets is the amount of n-6 or n-3 fatty acids. Since menhaden oil contains low levels 
of cholesterol, cholesterol was added to the MIX diets to maintain the cholesterol levels 
consistent in both MIX and fish oil diets. 
4.1.1 Effect of fish oil on plasma lipids 
Plasma cholesterol and triacylglycerol concentrations were higher in fish oil diet 
fed hamsters compared to MIX diet fed hamsters, which was dependent on the dietary fat 
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level (Figure 3.1-3.4). In addition, dietary cholesterol level dependent 
hypercholesterolemic and hypertriglyceridemic effects were observed in fish oil diet fed 
hamsters. Interestingly, these effects were attenuated in MIX diet fed hamsters. A 
hypercholesterolemic effect of fish oil has been observed in previous studies especially 
when diets are fed with moderate to high levels of cholesterol in hamsters (Surette et al., 
1992a, Lin at al., 1995, Lu et al., 1996, Kubow., 1996) and this effect was dependent on 
dietary cholesterol level and fat level (Surette et al., 1992a). Furthermore, this 
hypercholesterolemic effect was mainly attributed to changes in plasma VLDL and LDL 
cholesterol concentrations. In addition, these studies have postulated that the 
hypercholesterolemic effect of fish oil might be due to decreased catabolism ofVLDL · 
(Lin at a., 1995) and suppressed LDLr mediated removal ofLDL (Surette et al., 1992). 
However, none of the above studies observed a hypertriglyceridemic effect of fish oil. 
4.1.2 Effect of fish oil on VLDL lipid composition 
Many studies have shown beneficial effects of fish oil in lowering the plasma 
VLDL levels in humans (Nestel et al., 1984, Wong et al. , 1987). However, studies in the 
hamster model indicate elevation ofVLDL cholesterol by fish oil feeding (Surette et al., 
1992a, Lu et al., 1996, Kubow et al., 1996 Lin at al., 1995) with no change in VLDL 
triacylglycerol concentrations. We found that feeding fish oil for two weeks to FIB 
hamsters, a strain susceptible to diet induced hyperlipidemia, increases plasma VLDL 
and LDL lipids compared to hamsters fed a MIX diet rich in n-6 PUF A. Furthermore, 
this hyperlipidemic effect was dependent on the dietary fat level and cholesterol level. 
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Surette at al. (1992a) observed that an incremental increase in dietary n-3 PUF A 
from fish oil increases plasma VLDL cholesterol concentrations in Syrian golden 
hamsters when the diet is supplemented with 0.1% (w/w) cholesterol. However, with low 
dietary cholesterol (0.015% w/w), this dietary fat dependent hypercholesterolemic effect 
of fish oil was not seen. In our study, both the low fat fish oil and MIX diets contained 
0.025% (w/w) cholesterol but the hamsters fed the low fat fish oil diet showed higher 
levels ofVLDL- total cholesterol, triacylglycerols and phospholipid concentrations 
compared to hamsters fed the MIX diet (Figure 3.7-3.11). This suggests the possibility of 
an interaction of dietary cholesterol with fish oil in rendering the hyperlipidemic effect. 
Addition of cholesterol to the fish oil diet to a final concentration of 0.25% (w/w) 
increased all the VLDL lipids (Figure 3.7-3.11). Although, this dietary cholesterol 
dependent increase in VLDL lipids was also observed in MIX diet fed hamsters, the 
effect'onVLDL cholesterol was lower (Figure 3.7 and 3.9) compared to fish oil diet fed 
hamsters. This indicates that the hyperlipidemic effect of fish oil is due to a combination 
ofn-3 PUFA and the amount of dietary cholesterol, and that unlike n-3 PUFA, the n-6 
PUF A prevent cholesterol induced hyperlipidemia except at very high cholesterol 
concentrations. This suggestion is supported by the observations of previous studies that 
cholesterol supplementation at a level of0.5% (w/w) to both n-3 PUFA and n-6 PUFA, 
induce hypercholesterolemia in hamsters, and this effect was more prominent in n-3 
PUFA fed hamsters (Lin et al., 1995, Lu et al., 1996). 
The most interesting observation made in this study was that the plasma from 
hamsters fed high fat fish oil diets was packed with chylomicron like particles and very 
high levels ofVLDL that was rich in cholesterol and t1iacylglycerols. This observation 
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clearly delineates that the increase in VLDL and chylomicron by dietary fish oil is 
dependent on the dietary fat level. Since the high fat fish oil diet contains 0.1% (w/w) 
cholesterol compared to the low fat fish oil diet that contains 0.025% (w/w) cholesterol, 
the hyperlipidemic effect may not only be attributed to increased dietary fat level, but 
might be a result of an interaction between moderately high dietary cholesterol and high 
n-3 PUFA intake. 
4.1.2.1 Possible mechanisms for increased VLDL concentrations in fish oil fed 
hamsters 
4.1.2.1.1 Role of VLDL synthesis and secretion 
There is a possibility that higher VLDL cholesterol and triacylglycerol 
concentrations in fish oil fed hamsters is a result of increased hepatic secretion ofVLDL. 
The rate ofVLDL secretion is affected by the rate of endogenous production and 
exogenous supply of its contents and their precursors such as cholesterol, cholesterol 
ester, fatty acid, triacylglycerol, phospholipids, apoB and the activity of microsomal 
triglyceride transfer protein (MTTP) which plays the major role in the process of 
assembly ofVLDL particles in hepatocytes. We measured the changes in MTTP activity 
in hamsters fed various diets to understand whether increased MTTP activity contributes 
for increased VLDL levels (Figure 3.26). We observed that, at low dietary fat level there 
was no difference in MTTP activity between fish oil fed hamsters and MIX diet fed 
hamsters. The MTTP activity of high fat fish oil fed hamsters increased significantly (1.2 
fold) compared to MIX diet fed hamsters. However, the increase in VLDL 
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triacylglycerollevels is 7 fold. Thus, increased MTTP activity does not account for the 
massive increase in plasma VLDL concentrations in fish oil fed hamsters. Botham et al. 
(2003) has recently shown that the MTTP rnRNA expression in hepatocytes incubated 
with n-3 PUF A-enriched chylomicron remnants is not significantly different from 
hepatocytes incubated with chylomicron remnants rich in n-6 PUF A. These findings also 
imply that fish oil has no significant effect on MTTP activity compared to an n-6 PUFA 
rich diet, indicating that the increase in plasma VLDL levels is not due to induction of 
MTTP activity by fish oil. 
4.1.2.1.1.1 Fish oil decreases VLDL particle size 
Hamsters fed the fish oil diet had smaller VLDL particles compared to hamsters 
fed the MIX diet (Figure 3.33). This is consistent with the data showing that VLDL 
particles from hypertriglyceridemic patients fed fish oil are smaller than normal (Sullivan 
et al. , 1986). This reduction in particle size is reported to be due to hepatic secretion of 
smaller VLDL particles as a result of inhibition ofhepatic triacylglycerol synthesis by 
fish oil (Harris, 1989). Thus, decreased particle size ofVLDL from fish oil diet fed 
hamsters indicates a decrease in hepatic triacylglycerol synthesis, there by leading to 
smaller VLDL particles. 
4.1.2.1.2 Role of triacylglycerol clearance 
Another possible explanation for the increased VLDL concentration in fish oil fed 
hamsters is decreased removal ofVLDL triacylglycerol rich in n-3 PUF A. Increased 
levels of chylomicron like particles in high fat fish oil fed hamsters also raise the 
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possibility of reduced triacylglycerol clearance from plasma. Recent studies indicate that 
triacylglycerol, which are esterified with EPA and DHA are resistant to lipoprotein lipase 
mediated lipolysis (Botham et al., 1997, Levy et al., 1999, Oliveira et al. 1997) 
Lipoprotein lipase, located on the luminal surface of the blood vessels is 
responsible for hydrolysis ofVLDL and chylomicron triglycerides into glycerol and fatty 
acids, so that peripheral cells can consume the hydrolyzed products. Although this 
enzyme functions on the luminal surface of the blood vessels, it is synthesized mainly in 
the adipose and muscle parenchymal cells. The total adipose tissue lipoprotein lipase 
activity might indicate alterations in overall lipoprotein lipase activity in the plasma. 
However, it is not an accurate reflection oflipoprotein lipase activity as both lipoprotein 
lipase and hormone sensitive lipase activities are measured. We measured the lipoprotein 
lipase activity of white adipose tissue (Figure 3.27). There was a trend of increase in 
lipoprotein lipase activity in fish oil diet fed hamsters compared to MIX diet fed 
hamsters. High levels of lipoprotein lipase activity in adipose tissue were observed by 
Anil et al. (1992), Yoshiba et al. (1999) and Benhizia et al. (1994) in n-3 PUFA fed rats 
compared to n-6 PUF A fed rats, but this response occurred along with lower plasma 
triacylglycerol concentrations. As opposed to above observations, a decrease in post 
heparin lipoprotein lipase activity in fish oil fed swine (Groot et al. , 1989) and rats (Haug 
et al., 1987) has been reported with decreased plasma triacylglycerol concentrations. 
With the help of the latter fmdings, our results suggest that increased lipoprotein lipase 
activity observed in fish oil fed hamsters might be an adaptive response to clear elevated 
triacylglycerol from plasma. Since triacylglycerols, esterified with n-3 PUF A are known 
to be resistant to lipoprotein lipase mediated hydrolysis (Botham et al. , 1997, Levy et al., 
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1999, Oliveira et al. 1997), increased adipose tissue lipoprotein lipase activity in fish oil 
fed hamsters might be an adaptive response to maintain adequate supply of fatty acids 
and glycerol to peripheral cells. Furthermore, McAteer et al. (2003) demonstrated an 
association of increased accumulation of chylomicrons with decreased post-heparin 
lipoprotein lipase activity in F 1B hamsters fed a cholesterol supplemented diet. On the 
other hand, Harris et al. (1997) observed an increase in endogenous (nonheparin-
stimulated) lipoprotein lipase activity and decreased plasma triacylglycerol 
concentrations in healthy human subjects treated with fish oil concentrate. These studies 
show the critical role of intravascular lipase activity in regulating plasma triacylglycerol 
concentrations. We only measured the adipose tissue LPL activity, which is increased in 
fish oil fed hamsters. Thus, increased VLDL in fish oil fed hamsters cannot be explained 
based on adipose tissue LPL activity. 
In general, amount of dietary cholesterol had no effect on lipoprotein lipase 
activity in fish oil diet fed hamsters (Figure 3.27). However, there was decrease in 
lipoprotein lipase activity with addition of cholesterol to low fat fish oil diet. A dietary 
cholesterol dependent decrease in lipoprotein lipase activity has also been observed by 
McAteer et al. (2003) in F1B hamsters fed a cholesterol rich coconut oil diet. This 
suggests that the effect of dietary cholesterol on lipoprotein lipase activity can be 
modified by the type and amount of dietary fat. 
4.1.2.1.4 Do changes in chylomicron level modify VLDL clearance? 
It has been suggested that changes in plasma chylomicron levels can affect VLDL 
clearance due to alteration of the competition for lipoprotein lipase mediated catabolism 
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ofVLDL (Harris, 1989). We observed a marked increase in chylomicron like particles in 
high fat fish oil diet fed hamsters. Thus, there is a possibility that the very high levels of 
VLDL found in high fat fish oil fed hamsters might partly be due to increased 
competition for lipoprotein lipase mediated clearance. 
4.1.3 Effect of fish oil on LDL lipid composition 
The findings of previous studies on the influence ofn-3 PUFA on plasma LDL 
concentrations are inconsistent, especially in type-2 diabetes mellitus, where fish oil 
therapy is questioned. We found that LDL cholesterol, triacylglycerol and phospholipid 
concentrations were significantly higher in hamsters fed the fish oil diet compared to 
hamsters fed the MIX diet (Figure 3.12-3.17). 
In the present study, increased LDL cholesterol concentrations in fish oil diet fed 
hamsters are not associated with increase in dietary fat level. Interestingly, with the 
increase of dietary fat level, there was a decrease in total cholesterol and cholesterol ester 
concentrations in fish oil diet fed hamsters. On the other hand, LDL triacylglycerol 
concentrations showed a dietary fat level dependent increase in hamsters fed a fish oil 
diet. This dietary fat level dependent alteration in LDL composition might be attributed 
to fish oil-induced changes in cholesterol ester transfer between HDL and LDL. 
We observed an increase in LDL cholesterol and triacylglycerollevels with 
supplementation of cholesterol to fish oil diet, although the effect was prominent only at 
low dietary fat level (Figure 3.12-3.15). Unlike the fish oil diet, the MIX diet attenuated 
the cholesterol-induced elevation ofLDL cholesterol concentrations. It has been 
observed in Syrian golden hamsters that dietary cholesterol supplementation at a level of 
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0.5% w/w to a diet rich in n-3 PUF A or n-6 PUF A increase LDL cholesterol levels (Lin 
et al., 1995, Lu et al., 1996). However, the effect of addition of cholesterol was more 
prominent in n-3 PUF A rich diet fed hamsters (Lu et al., 1996). Together with the results 
of the previous studies, our observations suggest that the fish oil-induced increase in LDL 
cholesterol concentration is dependent on the amount of dietary cholesterol. The 
mechanisms involved in regulating plasma LDL levels are discussed below. 
Increased LDL lipids in fish oil fed hamsters might be due to increased LDL 
production from VLDL, decreased clearance of LDL from the plasma or increased 
transfer of cholesterol esters from HDL to LDL by reverse cholesterol transport pathway. 
4.1.3.1 Effect of fish oil on LDL production 
There is a possibility for increased production ofLDL from VLDL in fish oil diet 
fed hamsters, as the levels ofVLDL are significantly raised under these conditions 
(Figure 3.7). In addition, we observed a trend of increased adipose tissue lipoprotein 
lipase activity in fish oil fed hamsters (Figure 3.27). Increased plasma lipoprotein lipase 
activity and the availability of high levels ofVLDL might result in an increase in LDL 
levels. However, as discussed in section 4.1.2.1.2 there is a possibility of decreased 
intravascular lipase activity in fish oil fed hamsters rather than increased activity, 
although the lipoprotein lipase activity in adipose tissue is high. On the other hand, 
increased VLDL levels in fish oil diet fed hamsters are possibly due to decreased 
lipoprotein lipase mediated lipolysis rather than increased secretion ofVLDL. We have 
no evidence for fish oil induced increased VLDL secretion due to changes in MTTP 
activity. However, there is still a possibility of increased secretion ofVLDL and/or 
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increased breakdown ofVLDL to LDL. We did not measure post-heparin lipoprotein 
lipase activity or VLDL secretion, which might give a better understanding of fish oil 
mediated regulation ofVLDL and LDL synthesis. 
4.1.3.2 Effect of fish oil on LDL clearance 
The main way of LDL clearance from plasma is via hepatic LDL-receptor (LDLr) 
mediated LDL uptake, which can be modified by the levels ofLDLr mRNA expression 
or affinity ofLDL particles to LDL-receptors. We measured LDLr mRNA expression in 
the liver to investigate whether the increase in LDL levels might be due to down 
regulation ofLDLr mRNA levels. 
We observed a decrease in LDLr mRNA expression in fish oil fed hamsters at 
both low and high fat levels compared to MIX diet fed hamsters (Figure 3 .30). Fish oil 
induced suppression ofLDLr mRNA expression has also been observed previously in 
cell culture studies (Lindsey eta/., 1992) and animal studies (Wilkinson eta/., 1998). 
Thus, increased LDL levels in fish oil fed hamsters might be due to the suppression of 
LDLr mRNA expression. 
Furthermore, hamsters fed the high fat fish oil diet showed significantly lower 
levels ofLDLr mRNA abundance compared to low fat fish oil diet fed hamsters. This 
dietary fat level dependent suppression ofLDLr mRNA expression was associated with a 
dietary fat level dependent increase in LDL triacylglycerol concentrations (figure 3.15). 
However, hamsters fed the high fat fish oil diet showed decreased LDL cholesterol 
concentrations compared to hamsters fed low fat fish oil diet, which cannot be explained 
by modification ofLDLr mRNA expression. 
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We observed a decrease in LDLr mRNA expression in cholesterol supplemented 
MIX diet fed hamsters compared to hamsters fed MIX diet alone. Previous studies also 
have shown that dietary cholesterol down-regulates the expression ofLDLr mRNA in 
animals (Spady eta/., 1995) and healthy human subjects (Boucher eta/., 1998). 
Although with suppression of LDLr mRNA expression, elevation of plasma LDL 
cholesterol and triacylglycerol concentrations is expected in cholesterol supplemented 
MIX diet fed hamsters, plasma lipids remained similar to that of hamsters fed MIX diet 
alone. 
Dietary cholesterol supplementation had no effect on LDLr mRNA expression in 
fish oil diet fed hamsters. Furthermore, the increase in plasma LDL cholesterol 
concentrations with cholesterol supplementation to low fat fish oil diet cannot be 
explained by the changes ofLDLr mRNA abundance; These observations suggest that 
the influence of dietary cholesterol on plasma LDL levels in fish oil and MIX diet fed 
hamsters may not be attributed to LDLr mediated LDL uptake alone. 
4.1.3.2.1 Fish oil increases LDL particle size 
LDL particle size is known to be associated with LDLr affinity and hence LDLr 
mediated LDL uptake (Nigon eta/., 1991). There was an increase in LDL particle size in 
fish oil diet fed hamsters compared to MIX diet fed hamsters at both low and high dietary 
fat levels (Figure 3.31). The difference in particle size measured by electron microscopy 
was consistent with the LDL surface lipid: core lipid ratio (the lower the ratio, biggerthe 
particle size), which was lower in fish oil diet fed hamsters compared to MIX diet fed 
hamsters (Table 3.31). An increase in LDL particle size has also been observed in 
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hypertensive human subjects (Suzukawa et el., 1995) and in normal human subjects 
(Sanchez-muniz et al., 1999) following dietary supplementation of fish oil. According to 
these observations, it can be suggested that increased LDL levels in fish oil diet fed 
hamsters might partly be due to decreased affinity ofLDL particles to LDL-receptors 
because of increase in the LDL particle size, hence decreased hepatic LDL uptake. This 
hypothesis is further supported by the findings that larger or smaller LDL particles have 
less affinity for LDL-receptor compared to intermediate size particles (Nigon et al., 
1991). 
4.1.3.3 Fish oil suppresses cholesteryl ester transfer protein activity 
Cholesteryl ester transfer protein (CETP) plays the major role in transferring 
cholesterol ester from HDL to VLDL and LDL, in exchange for triacylglycerols (Quinet 
et al., 1991), thus determines plasma LDL and HDL composition. We measured the 
plasma CETP activity and CETP mass in hamsters fed fish oil and MIX diets to 
understand whether the increase in LDL and decrease in HDL levels in fish oil diet fed 
hamsters is due to increased CETP activity. There was a significant decrease in both 
CETP activity (Figure 3.28) and CETP mass (Figure 3.29) in fish oil diet fed hamsters 
irrespective of dietary fat level. Findings of studies done on hypercholesterolemic human 
subjects (Abbey eta!., 1990), normolipidemic patients with insulin dependent diabetes 
mellitus (Bagdade et al., 1996) and cell culture studies (Hirano et al., 2001) also suggest 
decreased reverse cholesterol transport from HDL to LDL following dietary 
supplementation ofn-3 PUFA. The CETP gene is activated by sterol regulatory element-
binding protein- I (SREBP1) (Chouinard et al., 1998) and fish oil is reported to suppress 
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SREBP1 by dietary fish oil has been reported (Kim eta!., 1999). Thus, the fish oil 
induced decrease in plasma CETP activity and CETP mass is possibly due to suppression 
of CETP gene expression. Although, CETP activity was lower in fish oil diet fed 
hamsters compared to MIX diet fed hamsters, the LDL cholesterol concentrations were 
higher and HDL cholesterol concentrations were lower. Thus, these fish oil-induced 
changes in LDL and HDL levels might not be attributed to fish oil-induced changes in 
plasma reverse cholesterol ester transfer. 
We observed a reduction in CETP mass with an increase of dietary fat level from 
5% to 20% w/w in fish oil fed hamsters. This might explain the high levels of 
triacylglycerol and low levels of cholesterol ester detected in LDL from high fat fish oil 
diet fed hamsters compared to that oflow fat fish oil diet fed hamster. However, in 
contrast to CETP mass, CETP activity did not change with the increase of dietary fat 
level. Since the plasma used for CETP activity assay in high fat fish oil fed hamsters 
contained very high levels of chylomicrorts, VLDL and LDL, which are potential 
acceptors of cholesterol esters from radiolabeled exogenous HDL, CETP activity of high 
fat fish oil fed hamsters might be an exaggerated reflection of CETP mass. 
Dietary cholesterol is known to suppress plasma CETP activity (Tall, 1995). 
However, the interactive effect of dietary cholesterol and n-3 PUFA on CETP activity, 
CETP mass and CETP gene expression is not yet known. Considering both CETP 
activity and CETP mass results, cholesterol supplementation caused an increase in 
plasma CETP activity in both fish oil and MIX diets fed hamsters. Fusegawa eta!. 
(2001) observed an increase in CETP activity in St. Kitts vervet monkeys with addition 
of cholesterol to diets rich in n-6 PUF A. These findings suggest that supplementation of 
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cholesterol to n-3 or n-6 PUF A enriched diet causes increase in CETP activity. The 
cholesterol-mediated increase in CETP activity is firmly associated with up regulation of 
the CETP gene and, interaction ofSREBPla, -2 and Yin Yang 1 (YYl) transcription 
factors with cholesterol (Gauthier et al., 1999). 
4.1.4 Effect of fish oil on HDL lipids 
HDL cholesterol and phospholipid concentrations were significantly lower in fish 
oil diet fed hamsters compared to MIX diet fed hamsters, while there was no difference in 
HDL triacylglycerol concentrations (Figure 3.17-3.21). Findings of previous studies 
done on hamsters (Kubow eta/., 1996, Surette et al., 1992a) and non-human primates 
(Ward et al., 1985) have shown decreased HDL cholesterol concentrations following fish 
oil feeding, which supports our observation. Plasma HDL cholesterol, triacylglycerol and 
phospholipid concentrations are mainly regulated by the reverse cholesterol transport 
pathway and cellular cholesterol and phospholipid efflux (Dietschy 1997, Bruce et al., 
1998). HDL acquires triacylglycerol from VLDL and LDL in exchange for cholesterol 
esters via the reverse cholesterol transport pathway and acquires cholesterol and 
phospholipids from peripheral cells. Reduction ofHDL cholesterol and phospholipid 
concentrations, with no change in triacylglycerol concentrations suggests that the fish oil 
induced HDL cholesterol lowering effect might be attributed to decreased efflux of 
cholesterol and phospholipids from peripheral cells rather than increased reverse 
cholesterol transport. Syeda et al. (2003) demonstrated that, cellular cholesterol efflux is 
positively correlated with HDL phospholipid concentrations and the efflux is not 
dependent on the plasma CETP activity. These fmdings are consistent with our results 
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that decreased HDL phospholipid concentrations in fish oil diet fed hamsters are 
associated with decreased HDL cholesterol concentrations, which reflects decreased 
cellular cholesterol efflux. 
Increasing the dietary fat level from 5% w/w to 20% w/w did not affect the HDL 
free cholesterol levels, but HDL cholesterol ester levels decreased significantly. This 
might be due to poor esterification ofHDL free cholesterol to cholesterol esters by 
lecithin cholesterol acyl transferase (LCAT) as n-3 PUF A are known to be less utilized 
by LCAT for the formation of cholesterol esters (Parks et a1., 1997, Parks et al., 1998). 
In the present study, there were significant increases in HDL cholesterol and 
phospholipid concentrations with addition of cholesterol to the fish oil diet. Similarly, 
Kubow et al. (1996) observed high levels ofHDL cholesterol in hamsters fed a fish oil 
diet supplemented with high cholesterol (0.88% w/w) compared to hamsters fed a fish oil 
diet supplemented with low cholesterol (0.285 w/w). Since HDL phospholipid 
concentrations are known to be positively correlated with cellular cholesterol efflux 
(Syeda et al., 2003), cholesterol-induced increase in HDL cholesterol concentrations in 
low fat fish oil fed hamsters might be due to increased cholesterol efflux from peripheral 
cells. 
4.2 Hepatic lipids in fish oil and MIX diet fed hamsters 
We observed lower hepatic total cholesterol, cholesterol ester and triacylglycerol 
levels in low fat fish oil diet fed hamsters compared to MIX diet fed hamsters (Figure 
3.22, 3.24 and 3.25). Similar results have been observed by Field et al. (1987) in rabbits 
fed a fish oil diet (1 0% w/w) compared with those fed a saturated fat diet. Furthermore, 
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Syrian golden hamsters fed a cholesterol supplemented fish oil diet showed a significant 
decrease in hepatic total cholesterol and cholesterol ester concentrations (Lin et al., 
1995). Both field et al. (1987) and Lin et al. (1995) observed that reduction in hepatic 
cholesterol concentrations was associated with high levels of microsomal acyl-
coenzymeA:cholesterol acyl transferase (ACAT) activity. Thus, lower hepatic 
cholesterol ester levels in low fat fish oil fed hamsters might be due to less availability of 
cholesterol for esterification resulting from suppressed LDLr mediated hepatic LDL 
uptake. Decreased hepatic triacylglycerollevels in fish oil diet fed hamsters might be 
due to fish oil-induced inhibition hepatic triacylglycerol synthesis that is established by 
several studies (Wong et al., 1984) 
In contrast to low fat fish oil diet fed hamsters, high fat fish oil diet fed hamsters 
had high levels ofhepatic cholesterol ester and triacylglycerollevels. These findings are 
supported by the observation made by Gaiva et al. (2003) in rats that showed higher 
levels ofhepatic lipids, lipogenesis and increase in liver weight following high fat fish oil 
diet (15% w/w) feeding compared to rats fed a soybean oil diet. However, they observed 
a concomitant decrease in plasma total lipid levels. Thus, increased levels of hepatic 
lipids in high fat fish oil diet fed hamsters might be due to increased accumulation and 
deposition oflipids resulted from fish oil-induced inhibition of VLDL secretion and/or 
increased hepatic lipogenesis. 
There was increased hepatic cholesterol ester and triacylglycerollevels in high 
fat fish oil diet fed hamsters compared to low fat fish oil diet fed hamsters. This dietary 
fat level dependent increase in hepatic lipid content might be due to increased hepatic 
lipogenesis rather than increased hepatic influx of dietary fats, as formation of 
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chylomicron remnants is possibly suppressed in high fat fish oil diet fed hamsters, that is 
discussed in section 4.1 .2.1.2. Although, the hepatic lipid content seems to be correlated 
with dietary fat level in fish oil diet fed hamsters, the effect of dietary fat level was 
attenuated in MIX diet fed hamsters (Figure 3.22-3.25). Similar results have been 
reported by Fungwe et al. (1993) in rats that were fed a cholesterol supplemented com oil 
diet (rich in n-6 PUF A) at 5% w/w and 20% w/w dietary fat levels; although both diets 
increased the hepatic lipid content compared to those fed a cholesterol free diet, there was 
no effect of dietary fat level. These findings suggest that the fish oil-induced increase in 
hepatic lipid content is dietary fat level dependent and a diet rich in n-6 PUF A attenuates 
the dietary fat level dependent increase in hepatic lipid content. 
Cholesterol supplemented diets fed hamsters had increased levels of hepatic total 
cholesterol and cholesterol ester compared to hamsters fed low fat diet alone. This effect 
was observed in both fish oil and MIX diets fed hamsters. Rats fed a low fat (5% w/w) 
com oil diet with incremental increase in cholesterol content showed elevation of hepatic 
free cholesterol and cholesterol ester levels (Fungwe et al., 1992). These findings 
support our results that cholesterol supplemented diets fed hamsters had increased levels 
of hepatic cholesterol ester compared to hamsters fed diets alone irrespective of the diet 
type. Since, dietary cholesterol is known to suppress hepatic cholesterol synthesis 
(Fungwe et al., 1992), the dietary cholesterol-induced increase in hepatic cholesterol 
content might be due to increased hepatic accumulation of cholesterol caused by 
increased hepatic uptake of cholesterol from plasma. On the other hand, the effect of 
dietary cholesterol on hepatic lipids was lesser in MIX diet fed hamsters compared to fish 
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oil diet fed hamsters, that implies the n-6 PUF A-mediated attenuation of cholesterol-
induced increase in hepatic cholesterol content. 
4.3 Role of oxidative stress in hyperlipidemic effect of fish oil 
Increased oxidative stress is known to be associated with increased tissue 
cholesterol (Chupukcharoan eta!., 1985) and increased LDL cholesterol (Katayama et 
al., 1991). Animal studies have shown a fish oil-induced reduction in anti-oxidant 
capacity of the body due to enhanced in vivo lipid peroxidation of n-3 PUF A (Sanders, 
1989). Moreover, administration of vitamin E could reverse a hyperlipidemic effect of 
fish oil, that was associated with lowered tissue lipid peroxidation in Syrian golden 
hamsters (Kubow et al., 1996). Kubow at al. (1996) further observed a highly significant 
correlation between serum levels of lipid peroxides and various lipoprotein fractions in 
fish oil fed hamsters. Thus, there is possibility that the dietary fat level dependent 
hyperlipidemic effect of fish oil in FlB hamsters might be due to increased oxidative 
stress rendered by increased peroxidation ofn-3 PUFA in tissue membranes. 
4.4 Conclusion and Future works 
Fish oil, in general is considered to be beneficial by lowering plasma 
triacylglycerol concentrations. However, the effect of fish oil on plasma LDL and HDL 
cholesterol concentrations is inconsistent. Our study showed that fish oil increases the 
cholesterol and triacylglycerol concentrations ofVLDL and LDL lipoprotein fractions 
while decreasing HDL cholesterol concentrations in F1B hamsters. The increase in 
plasma triacylglycerol concentrations was mainly attributed to increased VLDL and 
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chylomicron like particles. The increase in VLDL cholesterol and triacylglycerol 
concentrations was dependent on dietary fat level and dietary cholesterol level. Whether 
increased secretion or decreased removal caused increased VLDL levels could not be 
determined from our results. Future investigations need to be carried out to understand 
how fish oil modifies hepatic lipogenesis, fatty acid oxidation and the rates ofVLDL and 
apoB secretion. In addition, the effect of plasma and tissue antioxidant capacity on the 
fish oil-induced hyperlipidemic effect has to be investigated, since vitamin E 
supplementation is known to protect hamsters against this hyperlipidemic effect. Plasma 
post-heparin lipoprotein lipase activity, apoE and apoCII levels would give a better 
reflection of plasma VLDL and chylomicron catabolism. Increased LDL cholesterol and 
triacylglycerol concentrations in fish oil diet fed hamsters is probably due to decreased 
LDLr mediated LDL uptake, caused by suppression ofLDLr and/or increased LDL 
particle size. The decrease in HDL cholesterol concentrations in fish oil fed hamsters 
might not be dependent on plasma CETP activity. However, the mechanism behind fish 
oil-induced decrease in HDL cholesterol concentrations has to be investigated by future 
studies. 
This study shows that the changes in plasma lipoproteins with n-3 PUF A feeding 
in F1B hamsters are not consistent with the hypolipidemic and anti atherogenic properties 
of fish oil observed in other animal models and human trials. Fish oil is known to 
increase LDL-cholesterol concentration in human subjects with type-2 diabetes mellitus, 
although the mechanism of this increase is not known. Understanding the regulation of 
lipoprotein metabolism by fish oil in F 1B hamsters, a model susceptible to high fat-
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induced type-2 diabetes mellitus will shed new lights into the cause of fish oil-induced 
increase in LDL-cholesterol concentration and to design therapeutic strategies. 
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